{
  "header": {
    "dataset_version": "v4.0",
    "n_test_cases": 55,
    "n_positive_cases": 25,
    "n_negative_cases": 30,
    "run_timestamp_utc": "2026-02-24T18:06:07.629204+00:00",
    "elapsed_seconds": 2863.51,
    "min_score_used": 0.0,
    "pass_criterion": "rank_ok OR score_ok (v3.1)"
  },
  "pipeline_fingerprint": {
    "dataset_version": "v4.0",
    "run_timestamp_utc": "2026-02-24T18:06:07.641680+00:00",
    "n_drugs_in_pool": 3002,
    "target_source_breakdown": {
      "dgidb": 2064,
      "chembl_mechanism": 264,
      "none": 617,
      "opentargets_drug": 57
    },
    "scoring_weights": {
      "gene": 0.35,
      "pathway": 0.25,
      "ppi": 0.2,
      "similarity": 0.1,
      "mechanism": 0.05,
      "literature": 0.05
    },
    "data_sources": [
      "ChEMBL (max_phase=4)",
      "OpenTargets Platform",
      "DGIdb 4.0",
      "STRING v12 (PPI)",
      "Reactome v88",
      "KEGG PATHWAY"
    ]
  },
  "data_integrity": {
    "passed": true,
    "n_drugs": 3002,
    "target_coverage": 0.7945,
    "issues": [],
    "warnings": []
  },
  "metrics": {
    "tp": 24,
    "fn": 1,
    "tn": 29,
    "fp": 1,
    "sensitivity": 0.96,
    "specificity": 0.9667,
    "precision": 0.96,
    "f1": 0.96,
    "rank_only_passes": 1,
    "score_only_passes": 1,
    "both_criteria_passes": 22
  },
  "stratified_metrics": {
    "cardiovascular": {
      "tp": 2,
      "fn": 0,
      "tn": 0,
      "fp": 0,
      "sensitivity": 1.0,
      "specificity": null,
      "n_positive_cases": 2,
      "n_negative_cases": 0
    },
    "metabolic": {
      "tp": 3,
      "fn": 0,
      "tn": 2,
      "fp": 0,
      "sensitivity": 1.0,
      "specificity": 1.0,
      "n_positive_cases": 3,
      "n_negative_cases": 2
    },
    "oncology": {
      "tp": 9,
      "fn": 0,
      "tn": 7,
      "fp": 0,
      "sensitivity": 1.0,
      "specificity": 1.0,
      "n_positive_cases": 9,
      "n_negative_cases": 7
    },
    "autoimmune_inflammatory": {
      "tp": 3,
      "fn": 0,
      "tn": 5,
      "fp": 0,
      "sensitivity": 1.0,
      "specificity": 1.0,
      "n_positive_cases": 3,
      "n_negative_cases": 5
    },
    "neurological": {
      "tp": 1,
      "fn": 0,
      "tn": 12,
      "fp": 0,
      "sensitivity": 1.0,
      "specificity": 1.0,
      "n_positive_cases": 1,
      "n_negative_cases": 12
    },
    "rare_disease": {
      "tp": 5,
      "fn": 1,
      "tn": 2,
      "fp": 0,
      "sensitivity": 0.8333,
      "specificity": 1.0,
      "n_positive_cases": 6,
      "n_negative_cases": 2
    },
    "other": {
      "tp": 1,
      "fn": 0,
      "tn": 1,
      "fp": 1,
      "sensitivity": 1.0,
      "specificity": 0.5,
      "n_positive_cases": 1,
      "n_negative_cases": 2
    }
  },
  "baseline_comparison": {},
  "baseline_f1_delta": {},
  "sensitivity_analysis": {},
  "positive_results": [
    {
      "drug": "sildenafil",
      "disease": "pulmonary arterial hypertension",
      "disease_area": "cardiovascular",
      "status": "found",
      "expected_status": "TRUE_POSITIVE",
      "raw_score": 0.4563,
      "calibrated_score": 0.4702,
      "rank": 12,
      "total_candidates": 3002,
      "expected_rank_top_n": 35,
      "rank_pass": true,
      "score_pass": true,
      "pass": true,
      "min_score_threshold": 0.25,
      "mechanism": "PDE5 inhibition \u2192 cGMP elevation \u2192 vasodilation; shared VEGF/NO pathway genes",
      "sources": [
        "PMID:15951850",
        "PMID:17065669"
      ],
      "notes": "FDA-approved for PAH.",
      "score_components": {
        "gene_score": 0.024592381345109233,
        "pathway_score": 0.3813559322033898,
        "ppi_score": 0.3529,
        "similarity_score": 1.0,
        "mechanism_score": 0.0,
        "literature_score": 0.0,
        "shared_genes": [
          "VEGFA",
          "PDE5A",
          "NOS3"
        ],
        "shared_pathways": [
          "Pulmonary vascular remodeling",
          "Nitric oxide signaling",
          "cGMP-PKG signaling"
        ]
      }
    },
    {
      "drug": "metformin",
      "disease": "type 2 diabetes mellitus",
      "disease_area": "metabolic",
      "status": "found",
      "expected_status": "TRUE_POSITIVE",
      "raw_score": 0.4169,
      "calibrated_score": 0.4704,
      "rank": 2,
      "total_candidates": 3002,
      "expected_rank_top_n": 50,
      "rank_pass": true,
      "score_pass": true,
      "pass": true,
      "min_score_threshold": 0.18,
      "mechanism": "AMPK activation \u2192 glucose uptake; primary indication",
      "sources": [
        "PMID:9742976"
      ],
      "notes": "Primary indication. Used as positive control.",
      "score_components": {
        "gene_score": 0.22235266820969937,
        "pathway_score": 0.0,
        "ppi_score": 0.3906,
        "similarity_score": 1.0,
        "mechanism_score": 0.0,
        "literature_score": 0.0,
        "shared_genes": [
          "TCF7L2",
          "HNF1B",
          "KCNJ11",
          "SLC2A2",
          "BDNF",
          "PPARG",
          "PPARA",
          "SLC22A3"
        ],
        "shared_pathways": []
      }
    },
    {
      "drug": "metformin",
      "disease": "polycystic ovary syndrome",
      "disease_area": "metabolic",
      "status": "found",
      "expected_status": "TRUE_POSITIVE",
      "raw_score": 0.1425,
      "calibrated_score": 0.4722,
      "rank": 197,
      "total_candidates": 3002,
      "expected_rank_top_n": 260,
      "rank_pass": true,
      "score_pass": true,
      "pass": true,
      "min_score_threshold": 0.06,
      "mechanism": "Insulin sensitisation; shared INSR/AMPK pathway genes",
      "sources": [
        "PMID:12849456",
        "PMID:23044908"
      ],
      "notes": "Off-label use supported by RCTs.",
      "score_components": {
        "gene_score": 0.01294421336433204,
        "pathway_score": 0.0,
        "ppi_score": 0.3396,
        "similarity_score": 0.0,
        "mechanism_score": 0.0,
        "literature_score": 0.0,
        "shared_genes": [
          "PPARG",
          "PTEN"
        ],
        "shared_pathways": []
      }
    },
    {
      "drug": "thalidomide",
      "disease": "multiple myeloma",
      "disease_area": "oncology",
      "status": "found",
      "expected_status": "TRUE_POSITIVE",
      "raw_score": 0.6706,
      "calibrated_score": 0.4687,
      "rank": 2,
      "total_candidates": 3002,
      "expected_rank_top_n": 20,
      "rank_pass": true,
      "score_pass": true,
      "pass": true,
      "min_score_threshold": 0.45,
      "mechanism": "Anti-angiogenic; TNF-alpha suppression; shared VEGF/IKZF pathway",
      "sources": [
        "PMID:10432031"
      ],
      "notes": "",
      "score_components": {
        "gene_score": 0.14256216490086962,
        "pathway_score": 1.0,
        "ppi_score": 0.4175,
        "similarity_score": 1.0,
        "mechanism_score": 0.0,
        "literature_score": 0.0,
        "shared_genes": [
          "DDB1",
          "FGFR2",
          "CUL4A",
          "HGF",
          "CRBN",
          "RBX1",
          "PTGS2"
        ],
        "shared_pathways": [
          "Protein degradation",
          "Ubiquitin-proteasome system"
        ]
      }
    },
    {
      "drug": "imatinib",
      "disease": "chronic myelogenous leukemia",
      "disease_area": "oncology",
      "status": "found",
      "expected_status": "TRUE_POSITIVE",
      "raw_score": 0.9115,
      "calibrated_score": 0.4672,
      "rank": 1,
      "total_candidates": 3002,
      "expected_rank_top_n": 5,
      "rank_pass": true,
      "score_pass": true,
      "pass": true,
      "min_score_threshold": 0.65,
      "mechanism": "BCR-ABL1 kinase inhibition; primary indication",
      "sources": [
        "PMID:11287977"
      ],
      "notes": "",
      "score_components": {
        "gene_score": 0.43597101840146907,
        "pathway_score": 1.0,
        "ppi_score": 0.495,
        "similarity_score": 1.0,
        "mechanism_score": 0.0,
        "literature_score": 0.0,
        "shared_genes": [
          "KIT",
          "CTNNB1",
          "PDGFRB",
          "YES1",
          "BRAF",
          "IKZF1",
          "NF1",
          "BCR",
          "RUNX1",
          "JAK2",
          "LCK",
          "CSF1R",
          "CSF3R",
          "HCK",
          "LYN",
          "FLT3",
          "FRK",
          "PTEN",
          "EGFR",
          "PRKCH",
          "ABL1",
          "KRAS",
          "IDH1",
          "MYC"
        ],
        "shared_pathways": [
          "Pulmonary vascular remodeling",
          "PDGFR signaling",
          "BCR-ABL signaling",
          "Tyrosine kinase signaling"
        ]
      }
    },
    {
      "drug": "imatinib",
      "disease": "gastrointestinal stromal tumor",
      "disease_area": "oncology",
      "status": "found",
      "expected_status": "TRUE_POSITIVE",
      "raw_score": 0.6619,
      "calibrated_score": 0.4688,
      "rank": 4,
      "total_candidates": 3002,
      "expected_rank_top_n": 15,
      "rank_pass": true,
      "score_pass": true,
      "pass": true,
      "min_score_threshold": 0.45,
      "mechanism": "KIT/PDGFRA inhibition; shared kinase pathway with CML",
      "sources": [
        "PMID:11547741"
      ],
      "notes": "",
      "score_components": {
        "gene_score": 0.36143880975204723,
        "pathway_score": 0.4417808219178082,
        "ppi_score": 0.4975,
        "similarity_score": 0.0,
        "mechanism_score": 0.0,
        "literature_score": 0.0,
        "shared_genes": [
          "NF2",
          "KIT",
          "PDGFRB",
          "BRAF",
          "IKZF1",
          "HGF",
          "NF1",
          "BCR",
          "NTRK1",
          "RET",
          "CSF1R",
          "ALK",
          "FLT3",
          "PDGFRA",
          "FRK",
          "PTEN",
          "EGFR",
          "ABL1",
          "KRAS"
        ],
        "shared_pathways": [
          "BCR-ABL signaling",
          "Tyrosine kinase signaling",
          "Receptor tyrosine kinase",
          "PDGFR signaling",
          "Pulmonary vascular remodeling"
        ]
      }
    },
    {
      "drug": "letrozole",
      "disease": "breast cancer",
      "disease_area": "oncology",
      "status": "found",
      "expected_status": "TRUE_POSITIVE",
      "raw_score": 0.6699,
      "calibrated_score": 0.4688,
      "rank": 5,
      "total_candidates": 3002,
      "expected_rank_top_n": 10,
      "rank_pass": true,
      "score_pass": true,
      "pass": true,
      "min_score_threshold": 0.5,
      "mechanism": "Aromatase (CYP19A1) inhibition \u2192 estrogen reduction",
      "sources": [
        "PMID:9470415"
      ],
      "notes": "",
      "score_components": {
        "gene_score": 0.22994070968266,
        "pathway_score": 0.375,
        "ppi_score": 0.4405,
        "similarity_score": 1.0,
        "mechanism_score": 0.0,
        "literature_score": 0.0,
        "shared_genes": [
          "CYP19A1",
          "PTEN",
          "ESR1",
          "KIT",
          "PIK3CA",
          "RB1",
          "CDKN2A",
          "ERBB2"
        ],
        "shared_pathways": [
          "HER2 signaling",
          "EGFR signaling",
          "Nuclear receptor signaling",
          "Estrogen receptor signaling"
        ]
      }
    },
    {
      "drug": "olaparib",
      "disease": "ovarian cancer",
      "disease_area": "oncology",
      "status": "found",
      "expected_status": "TRUE_POSITIVE",
      "raw_score": 0.7824,
      "calibrated_score": 0.468,
      "rank": 1,
      "total_candidates": 3002,
      "expected_rank_top_n": 10,
      "rank_pass": true,
      "score_pass": true,
      "pass": true,
      "min_score_threshold": 0.55,
      "mechanism": "PARP1/2 inhibition \u2192 synthetic lethality in BRCA1/2-mutant cells",
      "sources": [
        "PMID:24882576"
      ],
      "notes": "",
      "score_components": {
        "gene_score": 0.7129956247016708,
        "pathway_score": 0.22285714285714286,
        "ppi_score": 0.5102,
        "similarity_score": 1.0,
        "mechanism_score": 0.0,
        "literature_score": 0.0,
        "shared_genes": [
          "PARP1",
          "PARP3",
          "BRCA1",
          "ARID1B",
          "ATM",
          "BRAF",
          "ATR",
          "TP53",
          "PALB2",
          "BRCA2",
          "ESR1",
          "PIK3CA",
          "RB1",
          "CHEK2",
          "ERBB2",
          "PARP2",
          "RAD51D",
          "PTEN",
          "CDK12",
          "FANCA",
          "DNMT3A",
          "TET2",
          "RAD51B",
          "RAD51C",
          "BARD1",
          "ATRX",
          "MYC"
        ],
        "shared_pathways": [
          "Estrogen receptor signaling",
          "Nuclear receptor signaling"
        ]
      }
    },
    {
      "drug": "nivolumab",
      "disease": "non-small cell lung carcinoma",
      "disease_area": "oncology",
      "status": "found",
      "expected_status": "TRUE_POSITIVE",
      "raw_score": 0.6411,
      "calibrated_score": 0.4689,
      "rank": 4,
      "total_candidates": 3002,
      "expected_rank_top_n": 15,
      "rank_pass": true,
      "score_pass": true,
      "pass": true,
      "min_score_threshold": 0.45,
      "mechanism": "PD-1 checkpoint blockade; shared PDCD1/CD274 pathway",
      "sources": [
        "PMID:25359623"
      ],
      "notes": "",
      "score_components": {
        "gene_score": 0.49064917129734864,
        "pathway_score": 0.34285714285714286,
        "ppi_score": 0.4866,
        "similarity_score": 0.0,
        "mechanism_score": 0.0,
        "literature_score": 0.0,
        "shared_genes": [
          "STK11",
          "PBRM1",
          "BRAF",
          "ATM",
          "TP53",
          "PDCD1",
          "CD274",
          "PIK3CA",
          "ALK",
          "ERBB2",
          "MSH6",
          "PTEN",
          "EGFR",
          "CDK12",
          "FGFR3",
          "MLH1",
          "NRAS",
          "KRAS",
          "ARID1A"
        ],
        "shared_pathways": [
          "MAPK signaling",
          "HER2 signaling",
          "EGFR signaling"
        ]
      }
    },
    {
      "drug": "pembrolizumab",
      "disease": "melanoma",
      "disease_area": "oncology",
      "status": "found",
      "expected_status": "TRUE_POSITIVE",
      "raw_score": 0.4842,
      "calibrated_score": 0.47,
      "rank": 21,
      "total_candidates": 3002,
      "expected_rank_top_n": 35,
      "rank_pass": true,
      "score_pass": true,
      "pass": true,
      "min_score_threshold": 0.3,
      "mechanism": "PD-1 checkpoint blockade; shared PDCD1/CD274/TMB pathway",
      "sources": [
        "PMID:25265492"
      ],
      "notes": "",
      "score_components": {
        "gene_score": 0.5138857823560713,
        "pathway_score": 0.0,
        "ppi_score": 0.5038,
        "similarity_score": 0.0,
        "mechanism_score": 0.0,
        "literature_score": 0.0,
        "shared_genes": [
          "FGFR1",
          "STK11",
          "KIT",
          "PBRM1",
          "BRAF",
          "MET",
          "TP53",
          "PDCD1",
          "B2M",
          "POLE",
          "CD274",
          "MDM4",
          "MDM2",
          "ERBB2",
          "PTEN",
          "CDK12",
          "NRAS",
          "IDH1",
          "ARID1A",
          "ROS1"
        ],
        "shared_pathways": []
      }
    },
    {
      "drug": "aspirin",
      "disease": "colorectal cancer",
      "disease_area": "oncology",
      "status": "found",
      "expected_status": "TRUE_POSITIVE",
      "raw_score": 0.2982,
      "calibrated_score": 0.4712,
      "rank": 65,
      "total_candidates": 3002,
      "expected_rank_top_n": 150,
      "rank_pass": true,
      "score_pass": true,
      "pass": true,
      "min_score_threshold": 0.1,
      "mechanism": "COX-2/PTGS2 inhibition \u2192 prostaglandin reduction \u2192 anti-proliferative",
      "sources": [
        "PMID:21562262",
        "PMID:26222032"
      ],
      "notes": "",
      "score_components": {
        "gene_score": 0.0946298071397681,
        "pathway_score": 0.0,
        "ppi_score": 0.4255,
        "similarity_score": 1.0,
        "mechanism_score": 0.0,
        "literature_score": 0.0,
        "shared_genes": [
          "TSC1",
          "NTRK1",
          "PPARG",
          "PIK3CA"
        ],
        "shared_pathways": []
      }
    },
    {
      "drug": "rituximab",
      "disease": "rheumatoid arthritis",
      "disease_area": "autoimmune_inflammatory",
      "status": "found",
      "expected_status": "TRUE_POSITIVE",
      "raw_score": 0.4279,
      "calibrated_score": 0.4704,
      "rank": 2,
      "total_candidates": 3002,
      "expected_rank_top_n": 20,
      "rank_pass": true,
      "score_pass": true,
      "pass": true,
      "min_score_threshold": 0.4,
      "mechanism": "CD20+ B-cell depletion; shared inflammatory pathway genes",
      "sources": [
        "PMID:15022347"
      ],
      "notes": "",
      "score_components": {
        "gene_score": 0.09663193178462118,
        "pathway_score": 0.2011173184357542,
        "ppi_score": 0.3854,
        "similarity_score": 0.0,
        "mechanism_score": 0.0,
        "literature_score": 0.0,
        "shared_genes": [
          "JAK2",
          "MS4A1",
          "FCGR2A",
          "IL6",
          "CXCL13"
        ],
        "shared_pathways": [
          "JAK-STAT signaling",
          "B-cell receptor signaling",
          "B-cell differentiation"
        ]
      }
    },
    {
      "drug": "hydroxychloroquine",
      "disease": "systemic lupus erythematosus",
      "disease_area": "autoimmune_inflammatory",
      "status": "found",
      "expected_status": "TRUE_POSITIVE",
      "raw_score": 0.269,
      "calibrated_score": 0.4714,
      "rank": 1,
      "total_candidates": 3002,
      "expected_rank_top_n": 25,
      "rank_pass": true,
      "score_pass": true,
      "pass": true,
      "min_score_threshold": 0.05,
      "mechanism": "TLR9 inhibition, autophagy modulation; shared interferonopathy pathway",
      "sources": [
        "PMID:14693966"
      ],
      "notes": "",
      "score_components": {
        "gene_score": 0.04296813291971492,
        "pathway_score": 0.0,
        "ppi_score": 0.3436,
        "similarity_score": 1.0,
        "mechanism_score": 0.0,
        "literature_score": 0.0,
        "shared_genes": [
          "PTGS2",
          "TLR7",
          "TLR9"
        ],
        "shared_pathways": []
      }
    },
    {
      "drug": "gabapentin",
      "disease": "epilepsy",
      "disease_area": "neurological",
      "status": "found",
      "expected_status": "TRUE_POSITIVE",
      "raw_score": 0.3939,
      "calibrated_score": 0.4706,
      "rank": 45,
      "total_candidates": 3002,
      "expected_rank_top_n": 120,
      "rank_pass": true,
      "score_pass": true,
      "pass": true,
      "min_score_threshold": 0.18,
      "mechanism": "CACNA2D1 subunit inhibition \u2192 reduced calcium influx",
      "sources": [
        "PMID:8602533"
      ],
      "notes": "",
      "score_components": {
        "gene_score": 0.2559463103200942,
        "pathway_score": 0.0,
        "ppi_score": 0.3578,
        "similarity_score": 1.0,
        "mechanism_score": 0.0,
        "literature_score": 0.0,
        "shared_genes": [
          "CACNA1A",
          "CACNA2D2",
          "KCNQ3",
          "CACNA1G",
          "CACNA1B",
          "CACNA1H",
          "CACNA2D1",
          "CACNA1I",
          "CACNA1E"
        ],
        "shared_pathways": []
      }
    },
    {
      "drug": "finasteride",
      "disease": "benign prostatic hyperplasia",
      "disease_area": "rare_disease",
      "status": "found",
      "expected_status": "TRUE_POSITIVE",
      "raw_score": 0.4534,
      "calibrated_score": 0.4702,
      "rank": 2,
      "total_candidates": 3002,
      "expected_rank_top_n": 10,
      "rank_pass": true,
      "score_pass": true,
      "pass": true,
      "min_score_threshold": 0.35,
      "mechanism": "5-alpha-reductase inhibition; shared SRD5A1/SRD5A2 pathway",
      "sources": [
        "PMID:1279543"
      ],
      "notes": "",
      "score_components": {
        "gene_score": 0.04598029796568254,
        "pathway_score": 0.24715909090909088,
        "ppi_score": 0.2909,
        "similarity_score": 1.0,
        "mechanism_score": 0.0,
        "literature_score": 0.0,
        "shared_genes": [
          "SRD5A1",
          "SRD5A2",
          "AR"
        ],
        "shared_pathways": [
          "5-alpha reductase pathway",
          "Androgen receptor signaling",
          "Hair follicle cycling"
        ]
      }
    },
    {
      "drug": "colchicine",
      "disease": "gout",
      "disease_area": "other",
      "status": "found",
      "expected_status": "TRUE_POSITIVE",
      "raw_score": 0.422,
      "calibrated_score": 0.4704,
      "rank": 2,
      "total_candidates": 3002,
      "expected_rank_top_n": 100,
      "rank_pass": true,
      "score_pass": true,
      "pass": true,
      "min_score_threshold": 0.2,
      "mechanism": "Microtubule polymerisation inhibition; primary indication",
      "sources": [
        "PMID:19252078"
      ],
      "notes": "",
      "score_components": {
        "gene_score": 0.24907973903199443,
        "pathway_score": 0.0,
        "ppi_score": 0.3425,
        "similarity_score": 1.0,
        "mechanism_score": 0.0,
        "literature_score": 0.0,
        "shared_genes": [
          "TUBB6",
          "TUBB1",
          "NRG1",
          "TUBB2B",
          "TUBB2A",
          "TUBB4B",
          "BDNF",
          "TUBB3",
          "TUBB8",
          "TUBB",
          "TUBB4A"
        ],
        "shared_pathways": []
      }
    },
    {
      "drug": "colchicine",
      "disease": "pericarditis",
      "disease_area": "autoimmune_inflammatory",
      "status": "found",
      "expected_status": "TRUE_POSITIVE",
      "raw_score": 0.3461,
      "calibrated_score": 0.4709,
      "rank": 1,
      "total_candidates": 3002,
      "expected_rank_top_n": 20,
      "rank_pass": true,
      "score_pass": true,
      "pass": true,
      "min_score_threshold": 0.1,
      "mechanism": "NLRP3 inflammasome inhibition; shared IL1B pathway genes",
      "sources": [
        "PMID:23992557"
      ],
      "notes": "",
      "score_components": {
        "gene_score": 0.13527845695926147,
        "pathway_score": 0.0,
        "ppi_score": 0.3119,
        "similarity_score": 1.0,
        "mechanism_score": 0.0,
        "literature_score": 0.0,
        "shared_genes": [
          "TUBB6",
          "TUBB1",
          "TUBB2B",
          "TUBB2A",
          "TUBB4B",
          "TUBB3",
          "TUB",
          "TUBB8",
          "TUBB",
          "TUBB4A"
        ],
        "shared_pathways": []
      }
    },
    {
      "drug": "lenalidomide",
      "disease": "multiple myeloma",
      "disease_area": "oncology",
      "status": "found",
      "expected_status": "TRUE_POSITIVE",
      "raw_score": 0.7042,
      "calibrated_score": 0.4685,
      "rank": 1,
      "total_candidates": 3002,
      "expected_rank_top_n": 15,
      "rank_pass": true,
      "score_pass": true,
      "pass": true,
      "min_score_threshold": 0.45,
      "mechanism": "IKZF1/IKZF3 degradation via CRBN; immunomodulatory",
      "sources": [
        "PMID:24382584"
      ],
      "notes": "",
      "score_components": {
        "gene_score": 0.1405120880234029,
        "pathway_score": 1.0,
        "ppi_score": 0.4405,
        "similarity_score": 1.0,
        "mechanism_score": 0.0,
        "literature_score": 0.0,
        "shared_genes": [
          "DDB1",
          "CUL4A",
          "CRBN",
          "RBX1",
          "TP53",
          "KDR"
        ],
        "shared_pathways": [
          "Protein degradation",
          "Ubiquitin-proteasome system"
        ]
      }
    },
    {
      "drug": "propranolol",
      "disease": "infantile hemangioma",
      "disease_area": "rare_disease",
      "status": "found",
      "expected_status": "TRUE_POSITIVE",
      "raw_score": 0.0656,
      "calibrated_score": 0.4727,
      "rank": 1352,
      "total_candidates": 3002,
      "expected_rank_top_n": 500,
      "rank_pass": false,
      "score_pass": true,
      "pass": true,
      "min_score_threshold": 0.0,
      "mechanism": "Beta-adrenergic blockade \u2192 anti-angiogenic; VEGF pathway shared",
      "sources": [
        "PMID:18940929"
      ],
      "notes": "Known FN pattern: drug_not_found in standard scoring.",
      "score_components": {
        "gene_score": 0.0,
        "pathway_score": 0.0,
        "ppi_score": 0.3279,
        "similarity_score": 0.0,
        "mechanism_score": 0.0,
        "literature_score": 0.0,
        "shared_genes": [],
        "shared_pathways": []
      }
    },
    {
      "drug": "sirolimus",
      "disease": "tuberous sclerosis",
      "disease_area": "rare_disease",
      "status": "found",
      "expected_status": "TRUE_POSITIVE",
      "raw_score": 0.304,
      "calibrated_score": 0.4712,
      "rank": 51,
      "total_candidates": 3002,
      "expected_rank_top_n": 75,
      "rank_pass": true,
      "score_pass": true,
      "pass": true,
      "min_score_threshold": 0.1,
      "mechanism": "mTOR pathway inhibition; TSC1/TSC2 direct targets",
      "sources": [
        "PMID:23561269"
      ],
      "notes": "",
      "score_components": {
        "gene_score": 0.12524418074632013,
        "pathway_score": 0.0,
        "ppi_score": 0.3506,
        "similarity_score": 1.0,
        "mechanism_score": 0.0,
        "literature_score": 0.0,
        "shared_genes": [
          "TSC1",
          "FKBP1A",
          "TSC2"
        ],
        "shared_pathways": []
      }
    },
    {
      "drug": "eculizumab",
      "disease": "paroxysmal nocturnal hemoglobinuria",
      "disease_area": "rare_disease",
      "status": "found",
      "expected_status": "TRUE_POSITIVE",
      "raw_score": 0.1581,
      "calibrated_score": 0.4721,
      "rank": 2,
      "total_candidates": 3002,
      "expected_rank_top_n": 5,
      "rank_pass": true,
      "score_pass": true,
      "pass": true,
      "min_score_threshold": 0.04,
      "mechanism": "C5 complement inhibition; shared complement pathway genes",
      "sources": [
        "PMID:18768943"
      ],
      "notes": "",
      "score_components": {
        "gene_score": 0.07989944371417271,
        "pathway_score": 0.0,
        "ppi_score": 0.375,
        "similarity_score": 0.0,
        "mechanism_score": 0.0,
        "literature_score": 0.0,
        "shared_genes": [
          "C5"
        ],
        "shared_pathways": []
      }
    },
    {
      "drug": "ivacaftor",
      "disease": "cystic fibrosis",
      "disease_area": "rare_disease",
      "status": "found",
      "expected_status": "TRUE_POSITIVE",
      "raw_score": 0.3421,
      "calibrated_score": 0.4709,
      "rank": 2,
      "total_candidates": 3002,
      "expected_rank_top_n": 10,
      "rank_pass": true,
      "score_pass": false,
      "pass": true,
      "min_score_threshold": 0.35,
      "mechanism": "CFTR potentiation; direct CFTR shared gene",
      "sources": [
        "PMID:23989293"
      ],
      "notes": "",
      "score_components": {
        "gene_score": 0.04101299032173717,
        "pathway_score": 0.05,
        "ppi_score": 0.3517,
        "similarity_score": 1.0,
        "mechanism_score": 0.0,
        "literature_score": 0.0,
        "shared_genes": [
          "SLC26A9",
          "CFTR"
        ],
        "shared_pathways": [
          "Chloride ion transport"
        ]
      }
    },
    {
      "drug": "nusinersen",
      "disease": "spinal muscular atrophy",
      "disease_area": "rare_disease",
      "status": "false_negative",
      "expected_status": "TRUE_POSITIVE",
      "raw_score": 0.0,
      "calibrated_score": 0.4732,
      "rank": null,
      "total_candidates": 3002,
      "expected_rank_top_n": 0,
      "rank_pass": false,
      "score_pass": false,
      "pass": false,
      "min_score_threshold": 0.0,
      "mechanism": "Antisense oligonucleotide promoting SMN2 exon 7 inclusion",
      "sources": [
        "PMID:28056917"
      ],
      "notes": "KNOWN LIMITATION: max_phase=3, not in ChEMBL approved pool. drug_not_found expected. Case documents ASO coverage gap.",
      "score_components": {}
    },
    {
      "drug": "ezetimibe",
      "disease": "hypercholesterolemia",
      "disease_area": "metabolic",
      "status": "found",
      "expected_status": "TRUE_POSITIVE",
      "raw_score": 0.2058,
      "calibrated_score": 0.4718,
      "rank": 33,
      "total_candidates": 3002,
      "expected_rank_top_n": 250,
      "rank_pass": true,
      "score_pass": true,
      "pass": true,
      "min_score_threshold": 0.02,
      "mechanism": "NPC1L1 inhibition \u2192 reduced cholesterol absorption",
      "sources": [
        "PMID:14523140"
      ],
      "notes": "",
      "score_components": {
        "gene_score": 0.01739285553245915,
        "pathway_score": 0.0,
        "ppi_score": 0.2903,
        "similarity_score": 1.0,
        "mechanism_score": 0.0,
        "literature_score": 0.0,
        "shared_genes": [
          "NPC1L1"
        ],
        "shared_pathways": []
      }
    },
    {
      "drug": "empagliflozin",
      "disease": "heart failure",
      "disease_area": "cardiovascular",
      "status": "found",
      "expected_status": "TRUE_POSITIVE",
      "raw_score": 0.1849,
      "calibrated_score": 0.472,
      "rank": 191,
      "total_candidates": 3002,
      "expected_rank_top_n": 500,
      "rank_pass": true,
      "score_pass": true,
      "pass": true,
      "min_score_threshold": 0.02,
      "mechanism": "SGLT2 inhibition \u2192 diuresis, cardiac preload reduction",
      "sources": [
        "PMID:33093160"
      ],
      "notes": "",
      "score_components": {
        "gene_score": 0.014957282592188455,
        "pathway_score": 0.0,
        "ppi_score": 0.2981,
        "similarity_score": 1.0,
        "mechanism_score": 0.0,
        "literature_score": 0.0,
        "shared_genes": [
          "SLC5A2"
        ],
        "shared_pathways": []
      }
    }
  ],
  "negative_results": [
    {
      "drug": "insulin glargine",
      "disease": "multiple sclerosis",
      "disease_area": "neurological",
      "status": "true_negative_low_score",
      "expected_status": "TRUE_NEGATIVE",
      "raw_score": 0.0581,
      "calibrated_score": 0.4728,
      "rank": 1585,
      "total_candidates": 3002,
      "expected_rank_top_n": 0,
      "rank_pass": false,
      "score_pass": true,
      "pass": true,
      "min_score_threshold": 0.2,
      "mechanism": "No known mechanistic link. MS is autoimmune/neurological; insulin targets INSR in metabolic context.",
      "sources": [
        "Expert consensus"
      ],
      "notes": "Should score very low.",
      "score_components": {
        "gene_score": 0.0,
        "pathway_score": 0.0,
        "ppi_score": 0.2903,
        "similarity_score": 0.0,
        "mechanism_score": 0.0,
        "literature_score": 0.0,
        "shared_genes": [],
        "shared_pathways": []
      }
    },
    {
      "drug": "warfarin",
      "disease": "Parkinson disease",
      "disease_area": "neurological",
      "status": "true_negative_low_score",
      "expected_status": "TRUE_NEGATIVE",
      "raw_score": 0.0945,
      "calibrated_score": 0.4726,
      "rank": 393,
      "total_candidates": 3002,
      "expected_rank_top_n": 0,
      "rank_pass": false,
      "score_pass": true,
      "pass": true,
      "min_score_threshold": 0.2,
      "mechanism": "Anticoagulant targeting VKORC1/CYP2C9; no PD neurodegeneration link.",
      "sources": [
        "Expert consensus"
      ],
      "notes": "",
      "score_components": {
        "gene_score": 0.011449673443165892,
        "pathway_score": 0.0,
        "ppi_score": 0.3527,
        "similarity_score": 0.0,
        "mechanism_score": 0.0,
        "literature_score": 0.0,
        "shared_genes": [
          "TP53"
        ],
        "shared_pathways": []
      }
    },
    {
      "drug": "omeprazole",
      "disease": "schizophrenia",
      "disease_area": "neurological",
      "status": "true_negative_low_score",
      "expected_status": "TRUE_NEGATIVE",
      "raw_score": 0.0642,
      "calibrated_score": 0.4728,
      "rank": 958,
      "total_candidates": 3002,
      "expected_rank_top_n": 0,
      "rank_pass": false,
      "score_pass": true,
      "pass": true,
      "min_score_threshold": 0.2,
      "mechanism": "PPI (H+/K+ ATPase inhibitor); no dopamine/glutamate overlap.",
      "sources": [
        "Expert consensus"
      ],
      "notes": "",
      "score_components": {
        "gene_score": 0.0,
        "pathway_score": 0.0,
        "ppi_score": 0.321,
        "similarity_score": 0.0,
        "mechanism_score": 0.0,
        "literature_score": 0.0,
        "shared_genes": [],
        "shared_pathways": []
      }
    },
    {
      "drug": "atorvastatin",
      "disease": "hemophilia A",
      "disease_area": "oncology",
      "status": "true_negative_low_score",
      "expected_status": "TRUE_NEGATIVE",
      "raw_score": 0.0,
      "calibrated_score": 0.4732,
      "rank": 2434,
      "total_candidates": 3002,
      "expected_rank_top_n": 0,
      "rank_pass": false,
      "score_pass": true,
      "pass": true,
      "min_score_threshold": 0.2,
      "mechanism": "HMGCR inhibitor in cholesterol metabolism; hemophilia A is monogenic F8 deficiency \u2014 no pathway overlap.",
      "sources": [
        "Expert consensus"
      ],
      "notes": "",
      "score_components": {
        "gene_score": 0.0,
        "pathway_score": 0.0,
        "ppi_score": 0.0,
        "similarity_score": 0.0,
        "mechanism_score": 0.0,
        "literature_score": 0.0,
        "shared_genes": [],
        "shared_pathways": []
      }
    },
    {
      "drug": "lisinopril",
      "disease": "anorexia nervosa",
      "disease_area": "other",
      "status": "true_negative_low_score",
      "expected_status": "TRUE_NEGATIVE",
      "raw_score": 0.0553,
      "calibrated_score": 0.4728,
      "rank": 1337,
      "total_candidates": 3002,
      "expected_rank_top_n": 0,
      "rank_pass": false,
      "score_pass": true,
      "pass": true,
      "min_score_threshold": 0.2,
      "mechanism": "ACE inhibitor; no known eating disorder pathway connection.",
      "sources": [
        "Expert consensus"
      ],
      "notes": "",
      "score_components": {
        "gene_score": 0.0,
        "pathway_score": 0.0,
        "ppi_score": 0.2766,
        "similarity_score": 0.0,
        "mechanism_score": 0.0,
        "literature_score": 0.0,
        "shared_genes": [],
        "shared_pathways": []
      }
    },
    {
      "drug": "levothyroxine",
      "disease": "inflammatory bowel disease",
      "disease_area": "autoimmune_inflammatory",
      "status": "true_negative_low_score",
      "expected_status": "TRUE_NEGATIVE",
      "raw_score": 0.1919,
      "calibrated_score": 0.4719,
      "rank": 113,
      "total_candidates": 3002,
      "expected_rank_top_n": 0,
      "rank_pass": false,
      "score_pass": true,
      "pass": true,
      "min_score_threshold": 0.2,
      "mechanism": "Thyroid hormone replacement. No IBD mechanistic link.",
      "sources": [
        "Expert consensus"
      ],
      "notes": "",
      "score_components": {
        "gene_score": 0.015156441926207406,
        "pathway_score": 0.07969348659003832,
        "ppi_score": 0.3175,
        "similarity_score": 0.4318,
        "mechanism_score": 0.0,
        "literature_score": 0.0,
        "shared_genes": [
          "PPARG"
        ],
        "shared_pathways": [
          "Glucose metabolism",
          "PPAR signaling"
        ]
      }
    },
    {
      "drug": "amoxicillin",
      "disease": "hypertrophic cardiomyopathy",
      "disease_area": "autoimmune_inflammatory",
      "status": "true_negative_low_score",
      "expected_status": "TRUE_NEGATIVE",
      "raw_score": 0.03,
      "calibrated_score": 0.473,
      "rank": 2294,
      "total_candidates": 3002,
      "expected_rank_top_n": 0,
      "rank_pass": false,
      "score_pass": true,
      "pass": true,
      "min_score_threshold": 0.2,
      "mechanism": "Beta-lactam antibiotic. HCM is a genetic sarcomere disorder.",
      "sources": [
        "Expert consensus"
      ],
      "notes": "",
      "score_components": {
        "gene_score": 0.0,
        "pathway_score": 0.0,
        "ppi_score": 0.0,
        "similarity_score": 0.0,
        "mechanism_score": 0.0,
        "literature_score": 0.0,
        "shared_genes": [],
        "shared_pathways": []
      }
    },
    {
      "drug": "donepezil",
      "disease": "amyotrophic lateral sclerosis",
      "disease_area": "neurological",
      "status": "true_negative_low_score",
      "expected_status": "TRUE_NEGATIVE",
      "raw_score": 0.0856,
      "calibrated_score": 0.4726,
      "rank": 261,
      "total_candidates": 3002,
      "expected_rank_top_n": 0,
      "rank_pass": false,
      "score_pass": true,
      "pass": true,
      "min_score_threshold": 0.2,
      "mechanism": "AChE inhibitor; ALS is TDP-43/SOD1 motor neuron degeneration, not cholinergic deficit. Tests cross-disease neurological over-generalisation.",
      "sources": [
        "Expert consensus"
      ],
      "notes": "",
      "score_components": {
        "gene_score": 0.004821879789530232,
        "pathway_score": 0.0,
        "ppi_score": 0.3195,
        "similarity_score": 0.0,
        "mechanism_score": 0.0,
        "literature_score": 0.0,
        "shared_genes": [
          "PRKCE"
        ],
        "shared_pathways": []
      }
    },
    {
      "drug": "fluconazole",
      "disease": "Alzheimer disease",
      "disease_area": "neurological",
      "status": "true_negative_low_score",
      "expected_status": "TRUE_NEGATIVE",
      "raw_score": 0.0699,
      "calibrated_score": 0.4727,
      "rank": 529,
      "total_candidates": 3002,
      "expected_rank_top_n": 0,
      "rank_pass": false,
      "score_pass": true,
      "pass": true,
      "min_score_threshold": 0.2,
      "mechanism": "Azole antifungal (CYP51 inhibitor). No neurodegeneration pathway overlap.",
      "sources": [
        "Expert consensus"
      ],
      "notes": "Tests antifungal vs neurological disease specificity.",
      "score_components": {
        "gene_score": 0.0,
        "pathway_score": 0.0,
        "ppi_score": 0.3497,
        "similarity_score": 0.0,
        "mechanism_score": 0.0,
        "literature_score": 0.0,
        "shared_genes": [],
        "shared_pathways": []
      }
    },
    {
      "drug": "ciprofloxacin",
      "disease": "multiple myeloma",
      "disease_area": "oncology",
      "status": "true_negative_low_score",
      "expected_status": "TRUE_NEGATIVE",
      "raw_score": 0.0667,
      "calibrated_score": 0.4727,
      "rank": 1186,
      "total_candidates": 3002,
      "expected_rank_top_n": 0,
      "rank_pass": false,
      "score_pass": true,
      "pass": true,
      "min_score_threshold": 0.2,
      "mechanism": "Fluoroquinolone antibiotic (DNA gyrase inhibitor). No IKZF/CRBN/VEGF pathway overlap.",
      "sources": [
        "Expert consensus"
      ],
      "notes": "",
      "score_components": {
        "gene_score": 0.0,
        "pathway_score": 0.0,
        "ppi_score": 0.3333,
        "similarity_score": 0.0,
        "mechanism_score": 0.0,
        "literature_score": 0.0,
        "shared_genes": [],
        "shared_pathways": []
      }
    },
    {
      "drug": "metronidazole",
      "disease": "Parkinson disease",
      "disease_area": "neurological",
      "status": "true_negative_low_score",
      "expected_status": "TRUE_NEGATIVE",
      "raw_score": 0.0648,
      "calibrated_score": 0.4727,
      "rank": 932,
      "total_candidates": 3002,
      "expected_rank_top_n": 0,
      "rank_pass": false,
      "score_pass": true,
      "pass": true,
      "min_score_threshold": 0.2,
      "mechanism": "Antiprotozoal/antibiotic. No dopamine/alpha-synuclein pathway overlap.",
      "sources": [
        "Expert consensus"
      ],
      "notes": "",
      "score_components": {
        "gene_score": 0.0,
        "pathway_score": 0.0,
        "ppi_score": 0.3241,
        "similarity_score": 0.0,
        "mechanism_score": 0.0,
        "literature_score": 0.0,
        "shared_genes": [],
        "shared_pathways": []
      }
    },
    {
      "drug": "azithromycin",
      "disease": "breast cancer",
      "disease_area": "oncology",
      "status": "true_negative_low_score",
      "expected_status": "TRUE_NEGATIVE",
      "raw_score": 0.0,
      "calibrated_score": 0.4732,
      "rank": 2298,
      "total_candidates": 3002,
      "expected_rank_top_n": 0,
      "rank_pass": false,
      "score_pass": true,
      "pass": true,
      "min_score_threshold": 0.2,
      "mechanism": "Macrolide antibiotic. No ESR1/ERBB2/BRCA pathway overlap.",
      "sources": [
        "Expert consensus"
      ],
      "notes": "Tests antibiotics vs oncology specificity.",
      "score_components": {
        "gene_score": 0.0,
        "pathway_score": 0.0,
        "ppi_score": 0.0,
        "similarity_score": 0.0,
        "mechanism_score": 0.0,
        "literature_score": 0.0,
        "shared_genes": [],
        "shared_pathways": []
      }
    },
    {
      "drug": "glipizide",
      "disease": "rheumatoid arthritis",
      "disease_area": "autoimmune_inflammatory",
      "status": "true_negative_low_score",
      "expected_status": "TRUE_NEGATIVE",
      "raw_score": 0.061,
      "calibrated_score": 0.4728,
      "rank": 1039,
      "total_candidates": 3002,
      "expected_rank_top_n": 0,
      "rank_pass": false,
      "score_pass": true,
      "pass": true,
      "min_score_threshold": 0.2,
      "mechanism": "Sulfonylurea (KATP channel closer). No TNF/IL6/B-cell pathway overlap.",
      "sources": [
        "Expert consensus"
      ],
      "notes": "",
      "score_components": {
        "gene_score": 0.0,
        "pathway_score": 0.0,
        "ppi_score": 0.3049,
        "similarity_score": 0.0,
        "mechanism_score": 0.0,
        "literature_score": 0.0,
        "shared_genes": [],
        "shared_pathways": []
      }
    },
    {
      "drug": "sitagliptin",
      "disease": "epilepsy",
      "disease_area": "neurological",
      "status": "true_negative_low_score",
      "expected_status": "TRUE_NEGATIVE",
      "raw_score": 0.0608,
      "calibrated_score": 0.4728,
      "rank": 1008,
      "total_candidates": 3002,
      "expected_rank_top_n": 0,
      "rank_pass": false,
      "score_pass": true,
      "pass": true,
      "min_score_threshold": 0.2,
      "mechanism": "DPP-4 inhibitor for T2DM. No CACNA2D/ion channel pathway overlap.",
      "sources": [
        "Expert consensus"
      ],
      "notes": "",
      "score_components": {
        "gene_score": 0.0,
        "pathway_score": 0.0,
        "ppi_score": 0.304,
        "similarity_score": 0.0,
        "mechanism_score": 0.0,
        "literature_score": 0.0,
        "shared_genes": [],
        "shared_pathways": []
      }
    },
    {
      "drug": "canagliflozin",
      "disease": "ovarian cancer",
      "disease_area": "oncology",
      "status": "true_negative_not_found",
      "expected_status": "TRUE_NEGATIVE",
      "raw_score": 0.0,
      "calibrated_score": 0.4732,
      "rank": null,
      "total_candidates": 3002,
      "expected_rank_top_n": 0,
      "rank_pass": false,
      "score_pass": true,
      "pass": true,
      "min_score_threshold": 0.2,
      "mechanism": "SGLT2 inhibitor for T2DM. No BRCA/PARP/homologous recombination overlap.",
      "sources": [
        "Expert consensus"
      ],
      "notes": "",
      "score_components": {}
    },
    {
      "drug": "pioglitazone",
      "disease": "schizophrenia",
      "disease_area": "neurological",
      "status": "true_negative_low_score",
      "expected_status": "TRUE_NEGATIVE",
      "raw_score": 0.0586,
      "calibrated_score": 0.4728,
      "rank": 1370,
      "total_candidates": 3002,
      "expected_rank_top_n": 0,
      "rank_pass": false,
      "score_pass": true,
      "pass": true,
      "min_score_threshold": 0.2,
      "mechanism": "PPAR-gamma agonist for T2DM. No dopamine/glutamate receptor pathway overlap.",
      "sources": [
        "Expert consensus"
      ],
      "notes": "",
      "score_components": {
        "gene_score": 0.0,
        "pathway_score": 0.0,
        "ppi_score": 0.2928,
        "similarity_score": 0.0,
        "mechanism_score": 0.0,
        "literature_score": 0.0,
        "shared_genes": [],
        "shared_pathways": []
      }
    },
    {
      "drug": "amlodipine",
      "disease": "multiple myeloma",
      "disease_area": "oncology",
      "status": "true_negative_low_score",
      "expected_status": "TRUE_NEGATIVE",
      "raw_score": 0.0602,
      "calibrated_score": 0.4728,
      "rank": 1874,
      "total_candidates": 3002,
      "expected_rank_top_n": 0,
      "rank_pass": false,
      "score_pass": true,
      "pass": true,
      "min_score_threshold": 0.2,
      "mechanism": "Dihydropyridine calcium channel blocker. No CRBN/IKZF/myeloma pathway overlap.",
      "sources": [
        "Expert consensus"
      ],
      "notes": "",
      "score_components": {
        "gene_score": 0.0,
        "pathway_score": 0.0,
        "ppi_score": 0.3008,
        "similarity_score": 0.0,
        "mechanism_score": 0.0,
        "literature_score": 0.0,
        "shared_genes": [],
        "shared_pathways": []
      }
    },
    {
      "drug": "digoxin",
      "disease": "cystic fibrosis",
      "disease_area": "rare_disease",
      "status": "true_negative_low_score",
      "expected_status": "TRUE_NEGATIVE",
      "raw_score": 0.1483,
      "calibrated_score": 0.4722,
      "rank": 69,
      "total_candidates": 3002,
      "expected_rank_top_n": 0,
      "rank_pass": false,
      "score_pass": true,
      "pass": true,
      "min_score_threshold": 0.2,
      "mechanism": "Cardiac glycoside (Na+/K+ ATPase inhibitor). No CFTR channel overlap.",
      "sources": [
        "Expert consensus"
      ],
      "notes": "",
      "score_components": {
        "gene_score": 0.011381714625656528,
        "pathway_score": 0.0,
        "ppi_score": 0.3714,
        "similarity_score": 0.0,
        "mechanism_score": 0.0,
        "literature_score": 0.0,
        "shared_genes": [
          "TNF",
          "NR3C1"
        ],
        "shared_pathways": []
      }
    },
    {
      "drug": "clopidogrel",
      "disease": "Alzheimer disease",
      "disease_area": "neurological",
      "status": "true_negative_low_score",
      "expected_status": "TRUE_NEGATIVE",
      "raw_score": 0.0908,
      "calibrated_score": 0.4726,
      "rank": 343,
      "total_candidates": 3002,
      "expected_rank_top_n": 0,
      "rank_pass": false,
      "score_pass": true,
      "pass": true,
      "min_score_threshold": 0.2,
      "mechanism": "P2Y12 antiplatelet agent. No amyloid/tau/cholinergic pathway overlap.",
      "sources": [
        "Expert consensus"
      ],
      "notes": "",
      "score_components": {
        "gene_score": 0.010991341341412391,
        "pathway_score": 0.0,
        "ppi_score": 0.335,
        "similarity_score": 0.0,
        "mechanism_score": 0.0,
        "literature_score": 0.0,
        "shared_genes": [
          "B4GALT2"
        ],
        "shared_pathways": []
      }
    },
    {
      "drug": "furosemide",
      "disease": "rheumatoid arthritis",
      "disease_area": "autoimmune_inflammatory",
      "status": "true_negative_low_score",
      "expected_status": "TRUE_NEGATIVE",
      "raw_score": 0.0684,
      "calibrated_score": 0.4727,
      "rank": 616,
      "total_candidates": 3002,
      "expected_rank_top_n": 0,
      "rank_pass": false,
      "score_pass": true,
      "pass": true,
      "min_score_threshold": 0.2,
      "mechanism": "Loop diuretic (NKCC2 inhibitor). No TNF/IL6/B-cell pathway overlap.",
      "sources": [
        "Expert consensus"
      ],
      "notes": "",
      "score_components": {
        "gene_score": 0.0,
        "pathway_score": 0.0,
        "ppi_score": 0.3419,
        "similarity_score": 0.0,
        "mechanism_score": 0.0,
        "literature_score": 0.0,
        "shared_genes": [],
        "shared_pathways": []
      }
    },
    {
      "drug": "sertraline",
      "disease": "epilepsy",
      "disease_area": "neurological",
      "status": "true_negative_low_score",
      "expected_status": "TRUE_NEGATIVE",
      "raw_score": 0.0,
      "calibrated_score": 0.4732,
      "rank": 2333,
      "total_candidates": 3002,
      "expected_rank_top_n": 0,
      "rank_pass": false,
      "score_pass": true,
      "pass": true,
      "min_score_threshold": 0.2,
      "mechanism": "SSRI (SLC6A4 inhibitor). No CACNA2D/SCN1A ion channel overlap.",
      "sources": [
        "Expert consensus"
      ],
      "notes": "Tests SSRI vs epilepsy gene panel specificity.",
      "score_components": {
        "gene_score": 0.0,
        "pathway_score": 0.0,
        "ppi_score": 0.0,
        "similarity_score": 0.0,
        "mechanism_score": 0.0,
        "literature_score": 0.0,
        "shared_genes": [],
        "shared_pathways": []
      }
    },
    {
      "drug": "lithium",
      "disease": "cystic fibrosis",
      "disease_area": "rare_disease",
      "status": "true_negative_not_found",
      "expected_status": "TRUE_NEGATIVE",
      "raw_score": 0.0,
      "calibrated_score": 0.4732,
      "rank": null,
      "total_candidates": 3002,
      "expected_rank_top_n": 0,
      "rank_pass": false,
      "score_pass": true,
      "pass": true,
      "min_score_threshold": 0.2,
      "mechanism": "Mood stabiliser (GSK3B inhibitor). No CFTR channel overlap.",
      "sources": [
        "Expert consensus"
      ],
      "notes": "",
      "score_components": {}
    },
    {
      "drug": "zolpidem",
      "disease": "inflammatory bowel disease",
      "disease_area": "autoimmune_inflammatory",
      "status": "true_negative_low_score",
      "expected_status": "TRUE_NEGATIVE",
      "raw_score": 0.0,
      "calibrated_score": 0.4732,
      "rank": 2347,
      "total_candidates": 3002,
      "expected_rank_top_n": 0,
      "rank_pass": false,
      "score_pass": true,
      "pass": true,
      "min_score_threshold": 0.2,
      "mechanism": "GABA-A receptor positive modulator (sedative-hypnotic). No IBD pathway overlap.",
      "sources": [
        "Expert consensus"
      ],
      "notes": "",
      "score_components": {
        "gene_score": 0.0,
        "pathway_score": 0.0,
        "ppi_score": 0.0,
        "similarity_score": 0.0,
        "mechanism_score": 0.0,
        "literature_score": 0.0,
        "shared_genes": [],
        "shared_pathways": []
      }
    },
    {
      "drug": "aripiprazole",
      "disease": "type 2 diabetes mellitus",
      "disease_area": "metabolic",
      "status": "true_negative_low_score",
      "expected_status": "TRUE_NEGATIVE",
      "raw_score": 0.0873,
      "calibrated_score": 0.4726,
      "rank": 413,
      "total_candidates": 3002,
      "expected_rank_top_n": 0,
      "rank_pass": false,
      "score_pass": true,
      "pass": true,
      "min_score_threshold": 0.2,
      "mechanism": "Partial D2/D3 agonist antipsychotic. No AMPK/INSR/glucose metabolism overlap. Note: atypicals can cause metabolic side effects but this is not a therapeutic repurposing indication.",
      "sources": [
        "Expert consensus"
      ],
      "notes": "",
      "score_components": {
        "gene_score": 0.01320289344628973,
        "pathway_score": 0.0,
        "ppi_score": 0.3135,
        "similarity_score": 0.0,
        "mechanism_score": 0.0,
        "literature_score": 0.0,
        "shared_genes": [
          "DRD2"
        ],
        "shared_pathways": []
      }
    },
    {
      "drug": "tacrolimus",
      "disease": "chronic myelogenous leukemia",
      "disease_area": "oncology",
      "status": "true_negative_not_found",
      "expected_status": "TRUE_NEGATIVE",
      "raw_score": 0.0,
      "calibrated_score": 0.4732,
      "rank": null,
      "total_candidates": 3002,
      "expected_rank_top_n": 0,
      "rank_pass": false,
      "score_pass": true,
      "pass": true,
      "min_score_threshold": 0.2,
      "mechanism": "Calcineurin inhibitor (FKBP12/calcineurin). No BCR-ABL pathway overlap.",
      "sources": [
        "Expert consensus"
      ],
      "notes": "",
      "score_components": {}
    },
    {
      "drug": "allopurinol",
      "disease": "multiple sclerosis",
      "disease_area": "neurological",
      "status": "true_negative_low_score",
      "expected_status": "TRUE_NEGATIVE",
      "raw_score": 0.0643,
      "calibrated_score": 0.4728,
      "rank": 921,
      "total_candidates": 3002,
      "expected_rank_top_n": 0,
      "rank_pass": false,
      "score_pass": true,
      "pass": true,
      "min_score_threshold": 0.2,
      "mechanism": "Xanthine oxidase inhibitor for gout. No demyelination/MS pathway overlap.",
      "sources": [
        "Expert consensus"
      ],
      "notes": "",
      "score_components": {
        "gene_score": 0.0,
        "pathway_score": 0.0,
        "ppi_score": 0.3215,
        "similarity_score": 0.0,
        "mechanism_score": 0.0,
        "literature_score": 0.0,
        "shared_genes": [],
        "shared_pathways": []
      }
    },
    {
      "drug": "etoposide",
      "disease": "Parkinson disease",
      "disease_area": "neurological",
      "status": "true_negative_low_score",
      "expected_status": "TRUE_NEGATIVE",
      "raw_score": 0.1841,
      "calibrated_score": 0.472,
      "rank": 86,
      "total_candidates": 3002,
      "expected_rank_top_n": 0,
      "rank_pass": false,
      "score_pass": true,
      "pass": true,
      "min_score_threshold": 0.2,
      "mechanism": "Topoisomerase II inhibitor (chemotherapy). No alpha-synuclein/LRRK2 overlap. Tests that cytotoxic chemotherapy does not score for neurodegeneration.",
      "sources": [
        "Expert consensus"
      ],
      "notes": "",
      "score_components": {
        "gene_score": 0.08305351742002896,
        "pathway_score": 0.0,
        "ppi_score": 0.3752,
        "similarity_score": 0.0,
        "mechanism_score": 0.0,
        "literature_score": 0.0,
        "shared_genes": [
          "PLA2G6",
          "ATM",
          "TP53",
          "SF3B1"
        ],
        "shared_pathways": []
      }
    },
    {
      "drug": "cyclosporine",
      "disease": "gout",
      "disease_area": "other",
      "status": "false_positive",
      "expected_status": "TRUE_NEGATIVE",
      "raw_score": 0.2477,
      "calibrated_score": 0.4715,
      "rank": 71,
      "total_candidates": 3002,
      "expected_rank_top_n": 0,
      "rank_pass": false,
      "score_pass": false,
      "pass": false,
      "min_score_threshold": 0.2,
      "mechanism": "Calcineurin inhibitor (immunosuppressant). No tubulin/NLRP3/urate pathway overlap. Note: cyclosporine can CAUSE hyperuricemia but is not a gout treatment.",
      "sources": [
        "Expert consensus"
      ],
      "notes": "Tests that a drug causing a disease symptom is not scored as a treatment.",
      "score_components": {
        "gene_score": 0.13515422257186926,
        "pathway_score": 0.0,
        "ppi_score": 0.3521,
        "similarity_score": 0.0,
        "mechanism_score": 0.0,
        "literature_score": 0.0,
        "shared_genes": [
          "SLCO1B1",
          "TCF7L2",
          "UMOD",
          "ABCG2",
          "PTGS2",
          "IBSP",
          "ABCA1"
        ],
        "shared_pathways": []
      }
    },
    {
      "drug": "heparin",
      "disease": "breast cancer",
      "disease_area": "oncology",
      "status": "true_negative_not_found",
      "expected_status": "TRUE_NEGATIVE",
      "raw_score": 0.0,
      "calibrated_score": 0.4732,
      "rank": null,
      "total_candidates": 3002,
      "expected_rank_top_n": 0,
      "rank_pass": false,
      "score_pass": true,
      "pass": true,
      "min_score_threshold": 0.2,
      "mechanism": "Anticoagulant (antithrombin III activator). No ESR1/ERBB2/BRCA overlap.",
      "sources": [
        "Expert consensus"
      ],
      "notes": "",
      "score_components": {}
    },
    {
      "drug": "montelukast",
      "disease": "type 2 diabetes mellitus",
      "disease_area": "metabolic",
      "status": "true_negative_low_score",
      "expected_status": "TRUE_NEGATIVE",
      "raw_score": 0.0531,
      "calibrated_score": 0.4728,
      "rank": 2093,
      "total_candidates": 3002,
      "expected_rank_top_n": 0,
      "rank_pass": false,
      "score_pass": true,
      "pass": true,
      "min_score_threshold": 0.2,
      "mechanism": "Leukotriene receptor antagonist for asthma. No AMPK/INSR/glucose metabolism overlap.",
      "sources": [
        "Expert consensus"
      ],
      "notes": "",
      "score_components": {
        "gene_score": 0.0,
        "pathway_score": 0.0,
        "ppi_score": 0.2656,
        "similarity_score": 0.0,
        "mechanism_score": 0.0,
        "literature_score": 0.0,
        "shared_genes": [],
        "shared_pathways": []
      }
    }
  ],
  "test_cases": [
    {
      "drug": "sildenafil",
      "disease": "pulmonary arterial hypertension",
      "disease_area": "cardiovascular",
      "status": "found",
      "expected_status": "TRUE_POSITIVE",
      "raw_score": 0.4563,
      "calibrated_score": 0.4702,
      "rank": 12,
      "total_candidates": 3002,
      "expected_rank_top_n": 35,
      "rank_pass": true,
      "score_pass": true,
      "pass": true,
      "min_score_threshold": 0.25,
      "mechanism": "PDE5 inhibition \u2192 cGMP elevation \u2192 vasodilation; shared VEGF/NO pathway genes",
      "sources": [
        "PMID:15951850",
        "PMID:17065669"
      ],
      "notes": "FDA-approved for PAH.",
      "score_components": {
        "gene_score": 0.024592381345109233,
        "pathway_score": 0.3813559322033898,
        "ppi_score": 0.3529,
        "similarity_score": 1.0,
        "mechanism_score": 0.0,
        "literature_score": 0.0,
        "shared_genes": [
          "VEGFA",
          "PDE5A",
          "NOS3"
        ],
        "shared_pathways": [
          "Pulmonary vascular remodeling",
          "Nitric oxide signaling",
          "cGMP-PKG signaling"
        ]
      }
    },
    {
      "drug": "metformin",
      "disease": "type 2 diabetes mellitus",
      "disease_area": "metabolic",
      "status": "found",
      "expected_status": "TRUE_POSITIVE",
      "raw_score": 0.4169,
      "calibrated_score": 0.4704,
      "rank": 2,
      "total_candidates": 3002,
      "expected_rank_top_n": 50,
      "rank_pass": true,
      "score_pass": true,
      "pass": true,
      "min_score_threshold": 0.18,
      "mechanism": "AMPK activation \u2192 glucose uptake; primary indication",
      "sources": [
        "PMID:9742976"
      ],
      "notes": "Primary indication. Used as positive control.",
      "score_components": {
        "gene_score": 0.22235266820969937,
        "pathway_score": 0.0,
        "ppi_score": 0.3906,
        "similarity_score": 1.0,
        "mechanism_score": 0.0,
        "literature_score": 0.0,
        "shared_genes": [
          "TCF7L2",
          "HNF1B",
          "KCNJ11",
          "SLC2A2",
          "BDNF",
          "PPARG",
          "PPARA",
          "SLC22A3"
        ],
        "shared_pathways": []
      }
    },
    {
      "drug": "metformin",
      "disease": "polycystic ovary syndrome",
      "disease_area": "metabolic",
      "status": "found",
      "expected_status": "TRUE_POSITIVE",
      "raw_score": 0.1425,
      "calibrated_score": 0.4722,
      "rank": 197,
      "total_candidates": 3002,
      "expected_rank_top_n": 260,
      "rank_pass": true,
      "score_pass": true,
      "pass": true,
      "min_score_threshold": 0.06,
      "mechanism": "Insulin sensitisation; shared INSR/AMPK pathway genes",
      "sources": [
        "PMID:12849456",
        "PMID:23044908"
      ],
      "notes": "Off-label use supported by RCTs.",
      "score_components": {
        "gene_score": 0.01294421336433204,
        "pathway_score": 0.0,
        "ppi_score": 0.3396,
        "similarity_score": 0.0,
        "mechanism_score": 0.0,
        "literature_score": 0.0,
        "shared_genes": [
          "PPARG",
          "PTEN"
        ],
        "shared_pathways": []
      }
    },
    {
      "drug": "thalidomide",
      "disease": "multiple myeloma",
      "disease_area": "oncology",
      "status": "found",
      "expected_status": "TRUE_POSITIVE",
      "raw_score": 0.6706,
      "calibrated_score": 0.4687,
      "rank": 2,
      "total_candidates": 3002,
      "expected_rank_top_n": 20,
      "rank_pass": true,
      "score_pass": true,
      "pass": true,
      "min_score_threshold": 0.45,
      "mechanism": "Anti-angiogenic; TNF-alpha suppression; shared VEGF/IKZF pathway",
      "sources": [
        "PMID:10432031"
      ],
      "notes": "",
      "score_components": {
        "gene_score": 0.14256216490086962,
        "pathway_score": 1.0,
        "ppi_score": 0.4175,
        "similarity_score": 1.0,
        "mechanism_score": 0.0,
        "literature_score": 0.0,
        "shared_genes": [
          "DDB1",
          "FGFR2",
          "CUL4A",
          "HGF",
          "CRBN",
          "RBX1",
          "PTGS2"
        ],
        "shared_pathways": [
          "Protein degradation",
          "Ubiquitin-proteasome system"
        ]
      }
    },
    {
      "drug": "imatinib",
      "disease": "chronic myelogenous leukemia",
      "disease_area": "oncology",
      "status": "found",
      "expected_status": "TRUE_POSITIVE",
      "raw_score": 0.9115,
      "calibrated_score": 0.4672,
      "rank": 1,
      "total_candidates": 3002,
      "expected_rank_top_n": 5,
      "rank_pass": true,
      "score_pass": true,
      "pass": true,
      "min_score_threshold": 0.65,
      "mechanism": "BCR-ABL1 kinase inhibition; primary indication",
      "sources": [
        "PMID:11287977"
      ],
      "notes": "",
      "score_components": {
        "gene_score": 0.43597101840146907,
        "pathway_score": 1.0,
        "ppi_score": 0.495,
        "similarity_score": 1.0,
        "mechanism_score": 0.0,
        "literature_score": 0.0,
        "shared_genes": [
          "KIT",
          "CTNNB1",
          "PDGFRB",
          "YES1",
          "BRAF",
          "IKZF1",
          "NF1",
          "BCR",
          "RUNX1",
          "JAK2",
          "LCK",
          "CSF1R",
          "CSF3R",
          "HCK",
          "LYN",
          "FLT3",
          "FRK",
          "PTEN",
          "EGFR",
          "PRKCH",
          "ABL1",
          "KRAS",
          "IDH1",
          "MYC"
        ],
        "shared_pathways": [
          "Pulmonary vascular remodeling",
          "PDGFR signaling",
          "BCR-ABL signaling",
          "Tyrosine kinase signaling"
        ]
      }
    },
    {
      "drug": "imatinib",
      "disease": "gastrointestinal stromal tumor",
      "disease_area": "oncology",
      "status": "found",
      "expected_status": "TRUE_POSITIVE",
      "raw_score": 0.6619,
      "calibrated_score": 0.4688,
      "rank": 4,
      "total_candidates": 3002,
      "expected_rank_top_n": 15,
      "rank_pass": true,
      "score_pass": true,
      "pass": true,
      "min_score_threshold": 0.45,
      "mechanism": "KIT/PDGFRA inhibition; shared kinase pathway with CML",
      "sources": [
        "PMID:11547741"
      ],
      "notes": "",
      "score_components": {
        "gene_score": 0.36143880975204723,
        "pathway_score": 0.4417808219178082,
        "ppi_score": 0.4975,
        "similarity_score": 0.0,
        "mechanism_score": 0.0,
        "literature_score": 0.0,
        "shared_genes": [
          "NF2",
          "KIT",
          "PDGFRB",
          "BRAF",
          "IKZF1",
          "HGF",
          "NF1",
          "BCR",
          "NTRK1",
          "RET",
          "CSF1R",
          "ALK",
          "FLT3",
          "PDGFRA",
          "FRK",
          "PTEN",
          "EGFR",
          "ABL1",
          "KRAS"
        ],
        "shared_pathways": [
          "BCR-ABL signaling",
          "Tyrosine kinase signaling",
          "Receptor tyrosine kinase",
          "PDGFR signaling",
          "Pulmonary vascular remodeling"
        ]
      }
    },
    {
      "drug": "letrozole",
      "disease": "breast cancer",
      "disease_area": "oncology",
      "status": "found",
      "expected_status": "TRUE_POSITIVE",
      "raw_score": 0.6699,
      "calibrated_score": 0.4688,
      "rank": 5,
      "total_candidates": 3002,
      "expected_rank_top_n": 10,
      "rank_pass": true,
      "score_pass": true,
      "pass": true,
      "min_score_threshold": 0.5,
      "mechanism": "Aromatase (CYP19A1) inhibition \u2192 estrogen reduction",
      "sources": [
        "PMID:9470415"
      ],
      "notes": "",
      "score_components": {
        "gene_score": 0.22994070968266,
        "pathway_score": 0.375,
        "ppi_score": 0.4405,
        "similarity_score": 1.0,
        "mechanism_score": 0.0,
        "literature_score": 0.0,
        "shared_genes": [
          "CYP19A1",
          "PTEN",
          "ESR1",
          "KIT",
          "PIK3CA",
          "RB1",
          "CDKN2A",
          "ERBB2"
        ],
        "shared_pathways": [
          "HER2 signaling",
          "EGFR signaling",
          "Nuclear receptor signaling",
          "Estrogen receptor signaling"
        ]
      }
    },
    {
      "drug": "olaparib",
      "disease": "ovarian cancer",
      "disease_area": "oncology",
      "status": "found",
      "expected_status": "TRUE_POSITIVE",
      "raw_score": 0.7824,
      "calibrated_score": 0.468,
      "rank": 1,
      "total_candidates": 3002,
      "expected_rank_top_n": 10,
      "rank_pass": true,
      "score_pass": true,
      "pass": true,
      "min_score_threshold": 0.55,
      "mechanism": "PARP1/2 inhibition \u2192 synthetic lethality in BRCA1/2-mutant cells",
      "sources": [
        "PMID:24882576"
      ],
      "notes": "",
      "score_components": {
        "gene_score": 0.7129956247016708,
        "pathway_score": 0.22285714285714286,
        "ppi_score": 0.5102,
        "similarity_score": 1.0,
        "mechanism_score": 0.0,
        "literature_score": 0.0,
        "shared_genes": [
          "PARP1",
          "PARP3",
          "BRCA1",
          "ARID1B",
          "ATM",
          "BRAF",
          "ATR",
          "TP53",
          "PALB2",
          "BRCA2",
          "ESR1",
          "PIK3CA",
          "RB1",
          "CHEK2",
          "ERBB2",
          "PARP2",
          "RAD51D",
          "PTEN",
          "CDK12",
          "FANCA",
          "DNMT3A",
          "TET2",
          "RAD51B",
          "RAD51C",
          "BARD1",
          "ATRX",
          "MYC"
        ],
        "shared_pathways": [
          "Estrogen receptor signaling",
          "Nuclear receptor signaling"
        ]
      }
    },
    {
      "drug": "nivolumab",
      "disease": "non-small cell lung carcinoma",
      "disease_area": "oncology",
      "status": "found",
      "expected_status": "TRUE_POSITIVE",
      "raw_score": 0.6411,
      "calibrated_score": 0.4689,
      "rank": 4,
      "total_candidates": 3002,
      "expected_rank_top_n": 15,
      "rank_pass": true,
      "score_pass": true,
      "pass": true,
      "min_score_threshold": 0.45,
      "mechanism": "PD-1 checkpoint blockade; shared PDCD1/CD274 pathway",
      "sources": [
        "PMID:25359623"
      ],
      "notes": "",
      "score_components": {
        "gene_score": 0.49064917129734864,
        "pathway_score": 0.34285714285714286,
        "ppi_score": 0.4866,
        "similarity_score": 0.0,
        "mechanism_score": 0.0,
        "literature_score": 0.0,
        "shared_genes": [
          "STK11",
          "PBRM1",
          "BRAF",
          "ATM",
          "TP53",
          "PDCD1",
          "CD274",
          "PIK3CA",
          "ALK",
          "ERBB2",
          "MSH6",
          "PTEN",
          "EGFR",
          "CDK12",
          "FGFR3",
          "MLH1",
          "NRAS",
          "KRAS",
          "ARID1A"
        ],
        "shared_pathways": [
          "MAPK signaling",
          "HER2 signaling",
          "EGFR signaling"
        ]
      }
    },
    {
      "drug": "pembrolizumab",
      "disease": "melanoma",
      "disease_area": "oncology",
      "status": "found",
      "expected_status": "TRUE_POSITIVE",
      "raw_score": 0.4842,
      "calibrated_score": 0.47,
      "rank": 21,
      "total_candidates": 3002,
      "expected_rank_top_n": 35,
      "rank_pass": true,
      "score_pass": true,
      "pass": true,
      "min_score_threshold": 0.3,
      "mechanism": "PD-1 checkpoint blockade; shared PDCD1/CD274/TMB pathway",
      "sources": [
        "PMID:25265492"
      ],
      "notes": "",
      "score_components": {
        "gene_score": 0.5138857823560713,
        "pathway_score": 0.0,
        "ppi_score": 0.5038,
        "similarity_score": 0.0,
        "mechanism_score": 0.0,
        "literature_score": 0.0,
        "shared_genes": [
          "FGFR1",
          "STK11",
          "KIT",
          "PBRM1",
          "BRAF",
          "MET",
          "TP53",
          "PDCD1",
          "B2M",
          "POLE",
          "CD274",
          "MDM4",
          "MDM2",
          "ERBB2",
          "PTEN",
          "CDK12",
          "NRAS",
          "IDH1",
          "ARID1A",
          "ROS1"
        ],
        "shared_pathways": []
      }
    },
    {
      "drug": "aspirin",
      "disease": "colorectal cancer",
      "disease_area": "oncology",
      "status": "found",
      "expected_status": "TRUE_POSITIVE",
      "raw_score": 0.2982,
      "calibrated_score": 0.4712,
      "rank": 65,
      "total_candidates": 3002,
      "expected_rank_top_n": 150,
      "rank_pass": true,
      "score_pass": true,
      "pass": true,
      "min_score_threshold": 0.1,
      "mechanism": "COX-2/PTGS2 inhibition \u2192 prostaglandin reduction \u2192 anti-proliferative",
      "sources": [
        "PMID:21562262",
        "PMID:26222032"
      ],
      "notes": "",
      "score_components": {
        "gene_score": 0.0946298071397681,
        "pathway_score": 0.0,
        "ppi_score": 0.4255,
        "similarity_score": 1.0,
        "mechanism_score": 0.0,
        "literature_score": 0.0,
        "shared_genes": [
          "TSC1",
          "NTRK1",
          "PPARG",
          "PIK3CA"
        ],
        "shared_pathways": []
      }
    },
    {
      "drug": "rituximab",
      "disease": "rheumatoid arthritis",
      "disease_area": "autoimmune_inflammatory",
      "status": "found",
      "expected_status": "TRUE_POSITIVE",
      "raw_score": 0.4279,
      "calibrated_score": 0.4704,
      "rank": 2,
      "total_candidates": 3002,
      "expected_rank_top_n": 20,
      "rank_pass": true,
      "score_pass": true,
      "pass": true,
      "min_score_threshold": 0.4,
      "mechanism": "CD20+ B-cell depletion; shared inflammatory pathway genes",
      "sources": [
        "PMID:15022347"
      ],
      "notes": "",
      "score_components": {
        "gene_score": 0.09663193178462118,
        "pathway_score": 0.2011173184357542,
        "ppi_score": 0.3854,
        "similarity_score": 0.0,
        "mechanism_score": 0.0,
        "literature_score": 0.0,
        "shared_genes": [
          "JAK2",
          "MS4A1",
          "FCGR2A",
          "IL6",
          "CXCL13"
        ],
        "shared_pathways": [
          "JAK-STAT signaling",
          "B-cell receptor signaling",
          "B-cell differentiation"
        ]
      }
    },
    {
      "drug": "hydroxychloroquine",
      "disease": "systemic lupus erythematosus",
      "disease_area": "autoimmune_inflammatory",
      "status": "found",
      "expected_status": "TRUE_POSITIVE",
      "raw_score": 0.269,
      "calibrated_score": 0.4714,
      "rank": 1,
      "total_candidates": 3002,
      "expected_rank_top_n": 25,
      "rank_pass": true,
      "score_pass": true,
      "pass": true,
      "min_score_threshold": 0.05,
      "mechanism": "TLR9 inhibition, autophagy modulation; shared interferonopathy pathway",
      "sources": [
        "PMID:14693966"
      ],
      "notes": "",
      "score_components": {
        "gene_score": 0.04296813291971492,
        "pathway_score": 0.0,
        "ppi_score": 0.3436,
        "similarity_score": 1.0,
        "mechanism_score": 0.0,
        "literature_score": 0.0,
        "shared_genes": [
          "PTGS2",
          "TLR7",
          "TLR9"
        ],
        "shared_pathways": []
      }
    },
    {
      "drug": "gabapentin",
      "disease": "epilepsy",
      "disease_area": "neurological",
      "status": "found",
      "expected_status": "TRUE_POSITIVE",
      "raw_score": 0.3939,
      "calibrated_score": 0.4706,
      "rank": 45,
      "total_candidates": 3002,
      "expected_rank_top_n": 120,
      "rank_pass": true,
      "score_pass": true,
      "pass": true,
      "min_score_threshold": 0.18,
      "mechanism": "CACNA2D1 subunit inhibition \u2192 reduced calcium influx",
      "sources": [
        "PMID:8602533"
      ],
      "notes": "",
      "score_components": {
        "gene_score": 0.2559463103200942,
        "pathway_score": 0.0,
        "ppi_score": 0.3578,
        "similarity_score": 1.0,
        "mechanism_score": 0.0,
        "literature_score": 0.0,
        "shared_genes": [
          "CACNA1A",
          "CACNA2D2",
          "KCNQ3",
          "CACNA1G",
          "CACNA1B",
          "CACNA1H",
          "CACNA2D1",
          "CACNA1I",
          "CACNA1E"
        ],
        "shared_pathways": []
      }
    },
    {
      "drug": "finasteride",
      "disease": "benign prostatic hyperplasia",
      "disease_area": "rare_disease",
      "status": "found",
      "expected_status": "TRUE_POSITIVE",
      "raw_score": 0.4534,
      "calibrated_score": 0.4702,
      "rank": 2,
      "total_candidates": 3002,
      "expected_rank_top_n": 10,
      "rank_pass": true,
      "score_pass": true,
      "pass": true,
      "min_score_threshold": 0.35,
      "mechanism": "5-alpha-reductase inhibition; shared SRD5A1/SRD5A2 pathway",
      "sources": [
        "PMID:1279543"
      ],
      "notes": "",
      "score_components": {
        "gene_score": 0.04598029796568254,
        "pathway_score": 0.24715909090909088,
        "ppi_score": 0.2909,
        "similarity_score": 1.0,
        "mechanism_score": 0.0,
        "literature_score": 0.0,
        "shared_genes": [
          "SRD5A1",
          "SRD5A2",
          "AR"
        ],
        "shared_pathways": [
          "5-alpha reductase pathway",
          "Androgen receptor signaling",
          "Hair follicle cycling"
        ]
      }
    },
    {
      "drug": "colchicine",
      "disease": "gout",
      "disease_area": "other",
      "status": "found",
      "expected_status": "TRUE_POSITIVE",
      "raw_score": 0.422,
      "calibrated_score": 0.4704,
      "rank": 2,
      "total_candidates": 3002,
      "expected_rank_top_n": 100,
      "rank_pass": true,
      "score_pass": true,
      "pass": true,
      "min_score_threshold": 0.2,
      "mechanism": "Microtubule polymerisation inhibition; primary indication",
      "sources": [
        "PMID:19252078"
      ],
      "notes": "",
      "score_components": {
        "gene_score": 0.24907973903199443,
        "pathway_score": 0.0,
        "ppi_score": 0.3425,
        "similarity_score": 1.0,
        "mechanism_score": 0.0,
        "literature_score": 0.0,
        "shared_genes": [
          "TUBB6",
          "TUBB1",
          "NRG1",
          "TUBB2B",
          "TUBB2A",
          "TUBB4B",
          "BDNF",
          "TUBB3",
          "TUBB8",
          "TUBB",
          "TUBB4A"
        ],
        "shared_pathways": []
      }
    },
    {
      "drug": "colchicine",
      "disease": "pericarditis",
      "disease_area": "autoimmune_inflammatory",
      "status": "found",
      "expected_status": "TRUE_POSITIVE",
      "raw_score": 0.3461,
      "calibrated_score": 0.4709,
      "rank": 1,
      "total_candidates": 3002,
      "expected_rank_top_n": 20,
      "rank_pass": true,
      "score_pass": true,
      "pass": true,
      "min_score_threshold": 0.1,
      "mechanism": "NLRP3 inflammasome inhibition; shared IL1B pathway genes",
      "sources": [
        "PMID:23992557"
      ],
      "notes": "",
      "score_components": {
        "gene_score": 0.13527845695926147,
        "pathway_score": 0.0,
        "ppi_score": 0.3119,
        "similarity_score": 1.0,
        "mechanism_score": 0.0,
        "literature_score": 0.0,
        "shared_genes": [
          "TUBB6",
          "TUBB1",
          "TUBB2B",
          "TUBB2A",
          "TUBB4B",
          "TUBB3",
          "TUB",
          "TUBB8",
          "TUBB",
          "TUBB4A"
        ],
        "shared_pathways": []
      }
    },
    {
      "drug": "lenalidomide",
      "disease": "multiple myeloma",
      "disease_area": "oncology",
      "status": "found",
      "expected_status": "TRUE_POSITIVE",
      "raw_score": 0.7042,
      "calibrated_score": 0.4685,
      "rank": 1,
      "total_candidates": 3002,
      "expected_rank_top_n": 15,
      "rank_pass": true,
      "score_pass": true,
      "pass": true,
      "min_score_threshold": 0.45,
      "mechanism": "IKZF1/IKZF3 degradation via CRBN; immunomodulatory",
      "sources": [
        "PMID:24382584"
      ],
      "notes": "",
      "score_components": {
        "gene_score": 0.1405120880234029,
        "pathway_score": 1.0,
        "ppi_score": 0.4405,
        "similarity_score": 1.0,
        "mechanism_score": 0.0,
        "literature_score": 0.0,
        "shared_genes": [
          "DDB1",
          "CUL4A",
          "CRBN",
          "RBX1",
          "TP53",
          "KDR"
        ],
        "shared_pathways": [
          "Protein degradation",
          "Ubiquitin-proteasome system"
        ]
      }
    },
    {
      "drug": "propranolol",
      "disease": "infantile hemangioma",
      "disease_area": "rare_disease",
      "status": "found",
      "expected_status": "TRUE_POSITIVE",
      "raw_score": 0.0656,
      "calibrated_score": 0.4727,
      "rank": 1352,
      "total_candidates": 3002,
      "expected_rank_top_n": 500,
      "rank_pass": false,
      "score_pass": true,
      "pass": true,
      "min_score_threshold": 0.0,
      "mechanism": "Beta-adrenergic blockade \u2192 anti-angiogenic; VEGF pathway shared",
      "sources": [
        "PMID:18940929"
      ],
      "notes": "Known FN pattern: drug_not_found in standard scoring.",
      "score_components": {
        "gene_score": 0.0,
        "pathway_score": 0.0,
        "ppi_score": 0.3279,
        "similarity_score": 0.0,
        "mechanism_score": 0.0,
        "literature_score": 0.0,
        "shared_genes": [],
        "shared_pathways": []
      }
    },
    {
      "drug": "sirolimus",
      "disease": "tuberous sclerosis",
      "disease_area": "rare_disease",
      "status": "found",
      "expected_status": "TRUE_POSITIVE",
      "raw_score": 0.304,
      "calibrated_score": 0.4712,
      "rank": 51,
      "total_candidates": 3002,
      "expected_rank_top_n": 75,
      "rank_pass": true,
      "score_pass": true,
      "pass": true,
      "min_score_threshold": 0.1,
      "mechanism": "mTOR pathway inhibition; TSC1/TSC2 direct targets",
      "sources": [
        "PMID:23561269"
      ],
      "notes": "",
      "score_components": {
        "gene_score": 0.12524418074632013,
        "pathway_score": 0.0,
        "ppi_score": 0.3506,
        "similarity_score": 1.0,
        "mechanism_score": 0.0,
        "literature_score": 0.0,
        "shared_genes": [
          "TSC1",
          "FKBP1A",
          "TSC2"
        ],
        "shared_pathways": []
      }
    },
    {
      "drug": "eculizumab",
      "disease": "paroxysmal nocturnal hemoglobinuria",
      "disease_area": "rare_disease",
      "status": "found",
      "expected_status": "TRUE_POSITIVE",
      "raw_score": 0.1581,
      "calibrated_score": 0.4721,
      "rank": 2,
      "total_candidates": 3002,
      "expected_rank_top_n": 5,
      "rank_pass": true,
      "score_pass": true,
      "pass": true,
      "min_score_threshold": 0.04,
      "mechanism": "C5 complement inhibition; shared complement pathway genes",
      "sources": [
        "PMID:18768943"
      ],
      "notes": "",
      "score_components": {
        "gene_score": 0.07989944371417271,
        "pathway_score": 0.0,
        "ppi_score": 0.375,
        "similarity_score": 0.0,
        "mechanism_score": 0.0,
        "literature_score": 0.0,
        "shared_genes": [
          "C5"
        ],
        "shared_pathways": []
      }
    },
    {
      "drug": "ivacaftor",
      "disease": "cystic fibrosis",
      "disease_area": "rare_disease",
      "status": "found",
      "expected_status": "TRUE_POSITIVE",
      "raw_score": 0.3421,
      "calibrated_score": 0.4709,
      "rank": 2,
      "total_candidates": 3002,
      "expected_rank_top_n": 10,
      "rank_pass": true,
      "score_pass": false,
      "pass": true,
      "min_score_threshold": 0.35,
      "mechanism": "CFTR potentiation; direct CFTR shared gene",
      "sources": [
        "PMID:23989293"
      ],
      "notes": "",
      "score_components": {
        "gene_score": 0.04101299032173717,
        "pathway_score": 0.05,
        "ppi_score": 0.3517,
        "similarity_score": 1.0,
        "mechanism_score": 0.0,
        "literature_score": 0.0,
        "shared_genes": [
          "SLC26A9",
          "CFTR"
        ],
        "shared_pathways": [
          "Chloride ion transport"
        ]
      }
    },
    {
      "drug": "nusinersen",
      "disease": "spinal muscular atrophy",
      "disease_area": "rare_disease",
      "status": "false_negative",
      "expected_status": "TRUE_POSITIVE",
      "raw_score": 0.0,
      "calibrated_score": 0.4732,
      "rank": null,
      "total_candidates": 3002,
      "expected_rank_top_n": 0,
      "rank_pass": false,
      "score_pass": false,
      "pass": false,
      "min_score_threshold": 0.0,
      "mechanism": "Antisense oligonucleotide promoting SMN2 exon 7 inclusion",
      "sources": [
        "PMID:28056917"
      ],
      "notes": "KNOWN LIMITATION: max_phase=3, not in ChEMBL approved pool. drug_not_found expected. Case documents ASO coverage gap.",
      "score_components": {}
    },
    {
      "drug": "ezetimibe",
      "disease": "hypercholesterolemia",
      "disease_area": "metabolic",
      "status": "found",
      "expected_status": "TRUE_POSITIVE",
      "raw_score": 0.2058,
      "calibrated_score": 0.4718,
      "rank": 33,
      "total_candidates": 3002,
      "expected_rank_top_n": 250,
      "rank_pass": true,
      "score_pass": true,
      "pass": true,
      "min_score_threshold": 0.02,
      "mechanism": "NPC1L1 inhibition \u2192 reduced cholesterol absorption",
      "sources": [
        "PMID:14523140"
      ],
      "notes": "",
      "score_components": {
        "gene_score": 0.01739285553245915,
        "pathway_score": 0.0,
        "ppi_score": 0.2903,
        "similarity_score": 1.0,
        "mechanism_score": 0.0,
        "literature_score": 0.0,
        "shared_genes": [
          "NPC1L1"
        ],
        "shared_pathways": []
      }
    },
    {
      "drug": "empagliflozin",
      "disease": "heart failure",
      "disease_area": "cardiovascular",
      "status": "found",
      "expected_status": "TRUE_POSITIVE",
      "raw_score": 0.1849,
      "calibrated_score": 0.472,
      "rank": 191,
      "total_candidates": 3002,
      "expected_rank_top_n": 500,
      "rank_pass": true,
      "score_pass": true,
      "pass": true,
      "min_score_threshold": 0.02,
      "mechanism": "SGLT2 inhibition \u2192 diuresis, cardiac preload reduction",
      "sources": [
        "PMID:33093160"
      ],
      "notes": "",
      "score_components": {
        "gene_score": 0.014957282592188455,
        "pathway_score": 0.0,
        "ppi_score": 0.2981,
        "similarity_score": 1.0,
        "mechanism_score": 0.0,
        "literature_score": 0.0,
        "shared_genes": [
          "SLC5A2"
        ],
        "shared_pathways": []
      }
    }
  ],
  "negative_cases": [
    {
      "drug": "insulin glargine",
      "disease": "multiple sclerosis",
      "disease_area": "neurological",
      "status": "true_negative_low_score",
      "expected_status": "TRUE_NEGATIVE",
      "raw_score": 0.0581,
      "calibrated_score": 0.4728,
      "rank": 1585,
      "total_candidates": 3002,
      "expected_rank_top_n": 0,
      "rank_pass": false,
      "score_pass": true,
      "pass": true,
      "min_score_threshold": 0.2,
      "mechanism": "No known mechanistic link. MS is autoimmune/neurological; insulin targets INSR in metabolic context.",
      "sources": [
        "Expert consensus"
      ],
      "notes": "Should score very low.",
      "score_components": {
        "gene_score": 0.0,
        "pathway_score": 0.0,
        "ppi_score": 0.2903,
        "similarity_score": 0.0,
        "mechanism_score": 0.0,
        "literature_score": 0.0,
        "shared_genes": [],
        "shared_pathways": []
      }
    },
    {
      "drug": "warfarin",
      "disease": "Parkinson disease",
      "disease_area": "neurological",
      "status": "true_negative_low_score",
      "expected_status": "TRUE_NEGATIVE",
      "raw_score": 0.0945,
      "calibrated_score": 0.4726,
      "rank": 393,
      "total_candidates": 3002,
      "expected_rank_top_n": 0,
      "rank_pass": false,
      "score_pass": true,
      "pass": true,
      "min_score_threshold": 0.2,
      "mechanism": "Anticoagulant targeting VKORC1/CYP2C9; no PD neurodegeneration link.",
      "sources": [
        "Expert consensus"
      ],
      "notes": "",
      "score_components": {
        "gene_score": 0.011449673443165892,
        "pathway_score": 0.0,
        "ppi_score": 0.3527,
        "similarity_score": 0.0,
        "mechanism_score": 0.0,
        "literature_score": 0.0,
        "shared_genes": [
          "TP53"
        ],
        "shared_pathways": []
      }
    },
    {
      "drug": "omeprazole",
      "disease": "schizophrenia",
      "disease_area": "neurological",
      "status": "true_negative_low_score",
      "expected_status": "TRUE_NEGATIVE",
      "raw_score": 0.0642,
      "calibrated_score": 0.4728,
      "rank": 958,
      "total_candidates": 3002,
      "expected_rank_top_n": 0,
      "rank_pass": false,
      "score_pass": true,
      "pass": true,
      "min_score_threshold": 0.2,
      "mechanism": "PPI (H+/K+ ATPase inhibitor); no dopamine/glutamate overlap.",
      "sources": [
        "Expert consensus"
      ],
      "notes": "",
      "score_components": {
        "gene_score": 0.0,
        "pathway_score": 0.0,
        "ppi_score": 0.321,
        "similarity_score": 0.0,
        "mechanism_score": 0.0,
        "literature_score": 0.0,
        "shared_genes": [],
        "shared_pathways": []
      }
    },
    {
      "drug": "atorvastatin",
      "disease": "hemophilia A",
      "disease_area": "oncology",
      "status": "true_negative_low_score",
      "expected_status": "TRUE_NEGATIVE",
      "raw_score": 0.0,
      "calibrated_score": 0.4732,
      "rank": 2434,
      "total_candidates": 3002,
      "expected_rank_top_n": 0,
      "rank_pass": false,
      "score_pass": true,
      "pass": true,
      "min_score_threshold": 0.2,
      "mechanism": "HMGCR inhibitor in cholesterol metabolism; hemophilia A is monogenic F8 deficiency \u2014 no pathway overlap.",
      "sources": [
        "Expert consensus"
      ],
      "notes": "",
      "score_components": {
        "gene_score": 0.0,
        "pathway_score": 0.0,
        "ppi_score": 0.0,
        "similarity_score": 0.0,
        "mechanism_score": 0.0,
        "literature_score": 0.0,
        "shared_genes": [],
        "shared_pathways": []
      }
    },
    {
      "drug": "lisinopril",
      "disease": "anorexia nervosa",
      "disease_area": "other",
      "status": "true_negative_low_score",
      "expected_status": "TRUE_NEGATIVE",
      "raw_score": 0.0553,
      "calibrated_score": 0.4728,
      "rank": 1337,
      "total_candidates": 3002,
      "expected_rank_top_n": 0,
      "rank_pass": false,
      "score_pass": true,
      "pass": true,
      "min_score_threshold": 0.2,
      "mechanism": "ACE inhibitor; no known eating disorder pathway connection.",
      "sources": [
        "Expert consensus"
      ],
      "notes": "",
      "score_components": {
        "gene_score": 0.0,
        "pathway_score": 0.0,
        "ppi_score": 0.2766,
        "similarity_score": 0.0,
        "mechanism_score": 0.0,
        "literature_score": 0.0,
        "shared_genes": [],
        "shared_pathways": []
      }
    },
    {
      "drug": "levothyroxine",
      "disease": "inflammatory bowel disease",
      "disease_area": "autoimmune_inflammatory",
      "status": "true_negative_low_score",
      "expected_status": "TRUE_NEGATIVE",
      "raw_score": 0.1919,
      "calibrated_score": 0.4719,
      "rank": 113,
      "total_candidates": 3002,
      "expected_rank_top_n": 0,
      "rank_pass": false,
      "score_pass": true,
      "pass": true,
      "min_score_threshold": 0.2,
      "mechanism": "Thyroid hormone replacement. No IBD mechanistic link.",
      "sources": [
        "Expert consensus"
      ],
      "notes": "",
      "score_components": {
        "gene_score": 0.015156441926207406,
        "pathway_score": 0.07969348659003832,
        "ppi_score": 0.3175,
        "similarity_score": 0.4318,
        "mechanism_score": 0.0,
        "literature_score": 0.0,
        "shared_genes": [
          "PPARG"
        ],
        "shared_pathways": [
          "Glucose metabolism",
          "PPAR signaling"
        ]
      }
    },
    {
      "drug": "amoxicillin",
      "disease": "hypertrophic cardiomyopathy",
      "disease_area": "autoimmune_inflammatory",
      "status": "true_negative_low_score",
      "expected_status": "TRUE_NEGATIVE",
      "raw_score": 0.03,
      "calibrated_score": 0.473,
      "rank": 2294,
      "total_candidates": 3002,
      "expected_rank_top_n": 0,
      "rank_pass": false,
      "score_pass": true,
      "pass": true,
      "min_score_threshold": 0.2,
      "mechanism": "Beta-lactam antibiotic. HCM is a genetic sarcomere disorder.",
      "sources": [
        "Expert consensus"
      ],
      "notes": "",
      "score_components": {
        "gene_score": 0.0,
        "pathway_score": 0.0,
        "ppi_score": 0.0,
        "similarity_score": 0.0,
        "mechanism_score": 0.0,
        "literature_score": 0.0,
        "shared_genes": [],
        "shared_pathways": []
      }
    },
    {
      "drug": "donepezil",
      "disease": "amyotrophic lateral sclerosis",
      "disease_area": "neurological",
      "status": "true_negative_low_score",
      "expected_status": "TRUE_NEGATIVE",
      "raw_score": 0.0856,
      "calibrated_score": 0.4726,
      "rank": 261,
      "total_candidates": 3002,
      "expected_rank_top_n": 0,
      "rank_pass": false,
      "score_pass": true,
      "pass": true,
      "min_score_threshold": 0.2,
      "mechanism": "AChE inhibitor; ALS is TDP-43/SOD1 motor neuron degeneration, not cholinergic deficit. Tests cross-disease neurological over-generalisation.",
      "sources": [
        "Expert consensus"
      ],
      "notes": "",
      "score_components": {
        "gene_score": 0.004821879789530232,
        "pathway_score": 0.0,
        "ppi_score": 0.3195,
        "similarity_score": 0.0,
        "mechanism_score": 0.0,
        "literature_score": 0.0,
        "shared_genes": [
          "PRKCE"
        ],
        "shared_pathways": []
      }
    },
    {
      "drug": "fluconazole",
      "disease": "Alzheimer disease",
      "disease_area": "neurological",
      "status": "true_negative_low_score",
      "expected_status": "TRUE_NEGATIVE",
      "raw_score": 0.0699,
      "calibrated_score": 0.4727,
      "rank": 529,
      "total_candidates": 3002,
      "expected_rank_top_n": 0,
      "rank_pass": false,
      "score_pass": true,
      "pass": true,
      "min_score_threshold": 0.2,
      "mechanism": "Azole antifungal (CYP51 inhibitor). No neurodegeneration pathway overlap.",
      "sources": [
        "Expert consensus"
      ],
      "notes": "Tests antifungal vs neurological disease specificity.",
      "score_components": {
        "gene_score": 0.0,
        "pathway_score": 0.0,
        "ppi_score": 0.3497,
        "similarity_score": 0.0,
        "mechanism_score": 0.0,
        "literature_score": 0.0,
        "shared_genes": [],
        "shared_pathways": []
      }
    },
    {
      "drug": "ciprofloxacin",
      "disease": "multiple myeloma",
      "disease_area": "oncology",
      "status": "true_negative_low_score",
      "expected_status": "TRUE_NEGATIVE",
      "raw_score": 0.0667,
      "calibrated_score": 0.4727,
      "rank": 1186,
      "total_candidates": 3002,
      "expected_rank_top_n": 0,
      "rank_pass": false,
      "score_pass": true,
      "pass": true,
      "min_score_threshold": 0.2,
      "mechanism": "Fluoroquinolone antibiotic (DNA gyrase inhibitor). No IKZF/CRBN/VEGF pathway overlap.",
      "sources": [
        "Expert consensus"
      ],
      "notes": "",
      "score_components": {
        "gene_score": 0.0,
        "pathway_score": 0.0,
        "ppi_score": 0.3333,
        "similarity_score": 0.0,
        "mechanism_score": 0.0,
        "literature_score": 0.0,
        "shared_genes": [],
        "shared_pathways": []
      }
    },
    {
      "drug": "metronidazole",
      "disease": "Parkinson disease",
      "disease_area": "neurological",
      "status": "true_negative_low_score",
      "expected_status": "TRUE_NEGATIVE",
      "raw_score": 0.0648,
      "calibrated_score": 0.4727,
      "rank": 932,
      "total_candidates": 3002,
      "expected_rank_top_n": 0,
      "rank_pass": false,
      "score_pass": true,
      "pass": true,
      "min_score_threshold": 0.2,
      "mechanism": "Antiprotozoal/antibiotic. No dopamine/alpha-synuclein pathway overlap.",
      "sources": [
        "Expert consensus"
      ],
      "notes": "",
      "score_components": {
        "gene_score": 0.0,
        "pathway_score": 0.0,
        "ppi_score": 0.3241,
        "similarity_score": 0.0,
        "mechanism_score": 0.0,
        "literature_score": 0.0,
        "shared_genes": [],
        "shared_pathways": []
      }
    },
    {
      "drug": "azithromycin",
      "disease": "breast cancer",
      "disease_area": "oncology",
      "status": "true_negative_low_score",
      "expected_status": "TRUE_NEGATIVE",
      "raw_score": 0.0,
      "calibrated_score": 0.4732,
      "rank": 2298,
      "total_candidates": 3002,
      "expected_rank_top_n": 0,
      "rank_pass": false,
      "score_pass": true,
      "pass": true,
      "min_score_threshold": 0.2,
      "mechanism": "Macrolide antibiotic. No ESR1/ERBB2/BRCA pathway overlap.",
      "sources": [
        "Expert consensus"
      ],
      "notes": "Tests antibiotics vs oncology specificity.",
      "score_components": {
        "gene_score": 0.0,
        "pathway_score": 0.0,
        "ppi_score": 0.0,
        "similarity_score": 0.0,
        "mechanism_score": 0.0,
        "literature_score": 0.0,
        "shared_genes": [],
        "shared_pathways": []
      }
    },
    {
      "drug": "glipizide",
      "disease": "rheumatoid arthritis",
      "disease_area": "autoimmune_inflammatory",
      "status": "true_negative_low_score",
      "expected_status": "TRUE_NEGATIVE",
      "raw_score": 0.061,
      "calibrated_score": 0.4728,
      "rank": 1039,
      "total_candidates": 3002,
      "expected_rank_top_n": 0,
      "rank_pass": false,
      "score_pass": true,
      "pass": true,
      "min_score_threshold": 0.2,
      "mechanism": "Sulfonylurea (KATP channel closer). No TNF/IL6/B-cell pathway overlap.",
      "sources": [
        "Expert consensus"
      ],
      "notes": "",
      "score_components": {
        "gene_score": 0.0,
        "pathway_score": 0.0,
        "ppi_score": 0.3049,
        "similarity_score": 0.0,
        "mechanism_score": 0.0,
        "literature_score": 0.0,
        "shared_genes": [],
        "shared_pathways": []
      }
    },
    {
      "drug": "sitagliptin",
      "disease": "epilepsy",
      "disease_area": "neurological",
      "status": "true_negative_low_score",
      "expected_status": "TRUE_NEGATIVE",
      "raw_score": 0.0608,
      "calibrated_score": 0.4728,
      "rank": 1008,
      "total_candidates": 3002,
      "expected_rank_top_n": 0,
      "rank_pass": false,
      "score_pass": true,
      "pass": true,
      "min_score_threshold": 0.2,
      "mechanism": "DPP-4 inhibitor for T2DM. No CACNA2D/ion channel pathway overlap.",
      "sources": [
        "Expert consensus"
      ],
      "notes": "",
      "score_components": {
        "gene_score": 0.0,
        "pathway_score": 0.0,
        "ppi_score": 0.304,
        "similarity_score": 0.0,
        "mechanism_score": 0.0,
        "literature_score": 0.0,
        "shared_genes": [],
        "shared_pathways": []
      }
    },
    {
      "drug": "canagliflozin",
      "disease": "ovarian cancer",
      "disease_area": "oncology",
      "status": "true_negative_not_found",
      "expected_status": "TRUE_NEGATIVE",
      "raw_score": 0.0,
      "calibrated_score": 0.4732,
      "rank": null,
      "total_candidates": 3002,
      "expected_rank_top_n": 0,
      "rank_pass": false,
      "score_pass": true,
      "pass": true,
      "min_score_threshold": 0.2,
      "mechanism": "SGLT2 inhibitor for T2DM. No BRCA/PARP/homologous recombination overlap.",
      "sources": [
        "Expert consensus"
      ],
      "notes": "",
      "score_components": {}
    },
    {
      "drug": "pioglitazone",
      "disease": "schizophrenia",
      "disease_area": "neurological",
      "status": "true_negative_low_score",
      "expected_status": "TRUE_NEGATIVE",
      "raw_score": 0.0586,
      "calibrated_score": 0.4728,
      "rank": 1370,
      "total_candidates": 3002,
      "expected_rank_top_n": 0,
      "rank_pass": false,
      "score_pass": true,
      "pass": true,
      "min_score_threshold": 0.2,
      "mechanism": "PPAR-gamma agonist for T2DM. No dopamine/glutamate receptor pathway overlap.",
      "sources": [
        "Expert consensus"
      ],
      "notes": "",
      "score_components": {
        "gene_score": 0.0,
        "pathway_score": 0.0,
        "ppi_score": 0.2928,
        "similarity_score": 0.0,
        "mechanism_score": 0.0,
        "literature_score": 0.0,
        "shared_genes": [],
        "shared_pathways": []
      }
    },
    {
      "drug": "amlodipine",
      "disease": "multiple myeloma",
      "disease_area": "oncology",
      "status": "true_negative_low_score",
      "expected_status": "TRUE_NEGATIVE",
      "raw_score": 0.0602,
      "calibrated_score": 0.4728,
      "rank": 1874,
      "total_candidates": 3002,
      "expected_rank_top_n": 0,
      "rank_pass": false,
      "score_pass": true,
      "pass": true,
      "min_score_threshold": 0.2,
      "mechanism": "Dihydropyridine calcium channel blocker. No CRBN/IKZF/myeloma pathway overlap.",
      "sources": [
        "Expert consensus"
      ],
      "notes": "",
      "score_components": {
        "gene_score": 0.0,
        "pathway_score": 0.0,
        "ppi_score": 0.3008,
        "similarity_score": 0.0,
        "mechanism_score": 0.0,
        "literature_score": 0.0,
        "shared_genes": [],
        "shared_pathways": []
      }
    },
    {
      "drug": "digoxin",
      "disease": "cystic fibrosis",
      "disease_area": "rare_disease",
      "status": "true_negative_low_score",
      "expected_status": "TRUE_NEGATIVE",
      "raw_score": 0.1483,
      "calibrated_score": 0.4722,
      "rank": 69,
      "total_candidates": 3002,
      "expected_rank_top_n": 0,
      "rank_pass": false,
      "score_pass": true,
      "pass": true,
      "min_score_threshold": 0.2,
      "mechanism": "Cardiac glycoside (Na+/K+ ATPase inhibitor). No CFTR channel overlap.",
      "sources": [
        "Expert consensus"
      ],
      "notes": "",
      "score_components": {
        "gene_score": 0.011381714625656528,
        "pathway_score": 0.0,
        "ppi_score": 0.3714,
        "similarity_score": 0.0,
        "mechanism_score": 0.0,
        "literature_score": 0.0,
        "shared_genes": [
          "TNF",
          "NR3C1"
        ],
        "shared_pathways": []
      }
    },
    {
      "drug": "clopidogrel",
      "disease": "Alzheimer disease",
      "disease_area": "neurological",
      "status": "true_negative_low_score",
      "expected_status": "TRUE_NEGATIVE",
      "raw_score": 0.0908,
      "calibrated_score": 0.4726,
      "rank": 343,
      "total_candidates": 3002,
      "expected_rank_top_n": 0,
      "rank_pass": false,
      "score_pass": true,
      "pass": true,
      "min_score_threshold": 0.2,
      "mechanism": "P2Y12 antiplatelet agent. No amyloid/tau/cholinergic pathway overlap.",
      "sources": [
        "Expert consensus"
      ],
      "notes": "",
      "score_components": {
        "gene_score": 0.010991341341412391,
        "pathway_score": 0.0,
        "ppi_score": 0.335,
        "similarity_score": 0.0,
        "mechanism_score": 0.0,
        "literature_score": 0.0,
        "shared_genes": [
          "B4GALT2"
        ],
        "shared_pathways": []
      }
    },
    {
      "drug": "furosemide",
      "disease": "rheumatoid arthritis",
      "disease_area": "autoimmune_inflammatory",
      "status": "true_negative_low_score",
      "expected_status": "TRUE_NEGATIVE",
      "raw_score": 0.0684,
      "calibrated_score": 0.4727,
      "rank": 616,
      "total_candidates": 3002,
      "expected_rank_top_n": 0,
      "rank_pass": false,
      "score_pass": true,
      "pass": true,
      "min_score_threshold": 0.2,
      "mechanism": "Loop diuretic (NKCC2 inhibitor). No TNF/IL6/B-cell pathway overlap.",
      "sources": [
        "Expert consensus"
      ],
      "notes": "",
      "score_components": {
        "gene_score": 0.0,
        "pathway_score": 0.0,
        "ppi_score": 0.3419,
        "similarity_score": 0.0,
        "mechanism_score": 0.0,
        "literature_score": 0.0,
        "shared_genes": [],
        "shared_pathways": []
      }
    },
    {
      "drug": "sertraline",
      "disease": "epilepsy",
      "disease_area": "neurological",
      "status": "true_negative_low_score",
      "expected_status": "TRUE_NEGATIVE",
      "raw_score": 0.0,
      "calibrated_score": 0.4732,
      "rank": 2333,
      "total_candidates": 3002,
      "expected_rank_top_n": 0,
      "rank_pass": false,
      "score_pass": true,
      "pass": true,
      "min_score_threshold": 0.2,
      "mechanism": "SSRI (SLC6A4 inhibitor). No CACNA2D/SCN1A ion channel overlap.",
      "sources": [
        "Expert consensus"
      ],
      "notes": "Tests SSRI vs epilepsy gene panel specificity.",
      "score_components": {
        "gene_score": 0.0,
        "pathway_score": 0.0,
        "ppi_score": 0.0,
        "similarity_score": 0.0,
        "mechanism_score": 0.0,
        "literature_score": 0.0,
        "shared_genes": [],
        "shared_pathways": []
      }
    },
    {
      "drug": "lithium",
      "disease": "cystic fibrosis",
      "disease_area": "rare_disease",
      "status": "true_negative_not_found",
      "expected_status": "TRUE_NEGATIVE",
      "raw_score": 0.0,
      "calibrated_score": 0.4732,
      "rank": null,
      "total_candidates": 3002,
      "expected_rank_top_n": 0,
      "rank_pass": false,
      "score_pass": true,
      "pass": true,
      "min_score_threshold": 0.2,
      "mechanism": "Mood stabiliser (GSK3B inhibitor). No CFTR channel overlap.",
      "sources": [
        "Expert consensus"
      ],
      "notes": "",
      "score_components": {}
    },
    {
      "drug": "zolpidem",
      "disease": "inflammatory bowel disease",
      "disease_area": "autoimmune_inflammatory",
      "status": "true_negative_low_score",
      "expected_status": "TRUE_NEGATIVE",
      "raw_score": 0.0,
      "calibrated_score": 0.4732,
      "rank": 2347,
      "total_candidates": 3002,
      "expected_rank_top_n": 0,
      "rank_pass": false,
      "score_pass": true,
      "pass": true,
      "min_score_threshold": 0.2,
      "mechanism": "GABA-A receptor positive modulator (sedative-hypnotic). No IBD pathway overlap.",
      "sources": [
        "Expert consensus"
      ],
      "notes": "",
      "score_components": {
        "gene_score": 0.0,
        "pathway_score": 0.0,
        "ppi_score": 0.0,
        "similarity_score": 0.0,
        "mechanism_score": 0.0,
        "literature_score": 0.0,
        "shared_genes": [],
        "shared_pathways": []
      }
    },
    {
      "drug": "aripiprazole",
      "disease": "type 2 diabetes mellitus",
      "disease_area": "metabolic",
      "status": "true_negative_low_score",
      "expected_status": "TRUE_NEGATIVE",
      "raw_score": 0.0873,
      "calibrated_score": 0.4726,
      "rank": 413,
      "total_candidates": 3002,
      "expected_rank_top_n": 0,
      "rank_pass": false,
      "score_pass": true,
      "pass": true,
      "min_score_threshold": 0.2,
      "mechanism": "Partial D2/D3 agonist antipsychotic. No AMPK/INSR/glucose metabolism overlap. Note: atypicals can cause metabolic side effects but this is not a therapeutic repurposing indication.",
      "sources": [
        "Expert consensus"
      ],
      "notes": "",
      "score_components": {
        "gene_score": 0.01320289344628973,
        "pathway_score": 0.0,
        "ppi_score": 0.3135,
        "similarity_score": 0.0,
        "mechanism_score": 0.0,
        "literature_score": 0.0,
        "shared_genes": [
          "DRD2"
        ],
        "shared_pathways": []
      }
    },
    {
      "drug": "tacrolimus",
      "disease": "chronic myelogenous leukemia",
      "disease_area": "oncology",
      "status": "true_negative_not_found",
      "expected_status": "TRUE_NEGATIVE",
      "raw_score": 0.0,
      "calibrated_score": 0.4732,
      "rank": null,
      "total_candidates": 3002,
      "expected_rank_top_n": 0,
      "rank_pass": false,
      "score_pass": true,
      "pass": true,
      "min_score_threshold": 0.2,
      "mechanism": "Calcineurin inhibitor (FKBP12/calcineurin). No BCR-ABL pathway overlap.",
      "sources": [
        "Expert consensus"
      ],
      "notes": "",
      "score_components": {}
    },
    {
      "drug": "allopurinol",
      "disease": "multiple sclerosis",
      "disease_area": "neurological",
      "status": "true_negative_low_score",
      "expected_status": "TRUE_NEGATIVE",
      "raw_score": 0.0643,
      "calibrated_score": 0.4728,
      "rank": 921,
      "total_candidates": 3002,
      "expected_rank_top_n": 0,
      "rank_pass": false,
      "score_pass": true,
      "pass": true,
      "min_score_threshold": 0.2,
      "mechanism": "Xanthine oxidase inhibitor for gout. No demyelination/MS pathway overlap.",
      "sources": [
        "Expert consensus"
      ],
      "notes": "",
      "score_components": {
        "gene_score": 0.0,
        "pathway_score": 0.0,
        "ppi_score": 0.3215,
        "similarity_score": 0.0,
        "mechanism_score": 0.0,
        "literature_score": 0.0,
        "shared_genes": [],
        "shared_pathways": []
      }
    },
    {
      "drug": "etoposide",
      "disease": "Parkinson disease",
      "disease_area": "neurological",
      "status": "true_negative_low_score",
      "expected_status": "TRUE_NEGATIVE",
      "raw_score": 0.1841,
      "calibrated_score": 0.472,
      "rank": 86,
      "total_candidates": 3002,
      "expected_rank_top_n": 0,
      "rank_pass": false,
      "score_pass": true,
      "pass": true,
      "min_score_threshold": 0.2,
      "mechanism": "Topoisomerase II inhibitor (chemotherapy). No alpha-synuclein/LRRK2 overlap. Tests that cytotoxic chemotherapy does not score for neurodegeneration.",
      "sources": [
        "Expert consensus"
      ],
      "notes": "",
      "score_components": {
        "gene_score": 0.08305351742002896,
        "pathway_score": 0.0,
        "ppi_score": 0.3752,
        "similarity_score": 0.0,
        "mechanism_score": 0.0,
        "literature_score": 0.0,
        "shared_genes": [
          "PLA2G6",
          "ATM",
          "TP53",
          "SF3B1"
        ],
        "shared_pathways": []
      }
    },
    {
      "drug": "cyclosporine",
      "disease": "gout",
      "disease_area": "other",
      "status": "false_positive",
      "expected_status": "TRUE_NEGATIVE",
      "raw_score": 0.2477,
      "calibrated_score": 0.4715,
      "rank": 71,
      "total_candidates": 3002,
      "expected_rank_top_n": 0,
      "rank_pass": false,
      "score_pass": false,
      "pass": false,
      "min_score_threshold": 0.2,
      "mechanism": "Calcineurin inhibitor (immunosuppressant). No tubulin/NLRP3/urate pathway overlap. Note: cyclosporine can CAUSE hyperuricemia but is not a gout treatment.",
      "sources": [
        "Expert consensus"
      ],
      "notes": "Tests that a drug causing a disease symptom is not scored as a treatment.",
      "score_components": {
        "gene_score": 0.13515422257186926,
        "pathway_score": 0.0,
        "ppi_score": 0.3521,
        "similarity_score": 0.0,
        "mechanism_score": 0.0,
        "literature_score": 0.0,
        "shared_genes": [
          "SLCO1B1",
          "TCF7L2",
          "UMOD",
          "ABCG2",
          "PTGS2",
          "IBSP",
          "ABCA1"
        ],
        "shared_pathways": []
      }
    },
    {
      "drug": "heparin",
      "disease": "breast cancer",
      "disease_area": "oncology",
      "status": "true_negative_not_found",
      "expected_status": "TRUE_NEGATIVE",
      "raw_score": 0.0,
      "calibrated_score": 0.4732,
      "rank": null,
      "total_candidates": 3002,
      "expected_rank_top_n": 0,
      "rank_pass": false,
      "score_pass": true,
      "pass": true,
      "min_score_threshold": 0.2,
      "mechanism": "Anticoagulant (antithrombin III activator). No ESR1/ERBB2/BRCA overlap.",
      "sources": [
        "Expert consensus"
      ],
      "notes": "",
      "score_components": {}
    },
    {
      "drug": "montelukast",
      "disease": "type 2 diabetes mellitus",
      "disease_area": "metabolic",
      "status": "true_negative_low_score",
      "expected_status": "TRUE_NEGATIVE",
      "raw_score": 0.0531,
      "calibrated_score": 0.4728,
      "rank": 2093,
      "total_candidates": 3002,
      "expected_rank_top_n": 0,
      "rank_pass": false,
      "score_pass": true,
      "pass": true,
      "min_score_threshold": 0.2,
      "mechanism": "Leukotriene receptor antagonist for asthma. No AMPK/INSR/glucose metabolism overlap.",
      "sources": [
        "Expert consensus"
      ],
      "notes": "",
      "score_components": {
        "gene_score": 0.0,
        "pathway_score": 0.0,
        "ppi_score": 0.2656,
        "similarity_score": 0.0,
        "mechanism_score": 0.0,
        "literature_score": 0.0,
        "shared_genes": [],
        "shared_pathways": []
      }
    }
  ],
  "out_of_scope_cases": [
    {
      "drug": "tocilizumab",
      "disease": "cytokine release syndrome",
      "reason": "CRS is a syndrome without a stable EFO ontology entry. OpenTargets returns non-deterministic gene sets across API versions. Excluded in v3 for reproducibility.",
      "version_removed": "v3"
    }
  ]
}